rfhg_100692.1

Basic information about the TSS

---

TSS ID: rfhg_100692.1 Species: human Chr: chr7		Start: 137879160 End: 137879170 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AL080209:-60 GeneID: 64764 HGNC/MGI_ID: HGNC:23720 UniProt_ID: Nearer transcript ids and distances:

Gene_name: cAMP responsive element binding protein 3 like 2 Gene_symbol: CREB3L2 Gene_synonyms: BBF2H7 TCAG_1951439 Gene_source: HGNC:23720

TATA-Box annotation

---

Distance to TSS:	-32301
Nearest PromoterID:	NM_004717
Entrez ID:	9162
Nearest Unigene:	Hs.242947
Nearest Refseq:	NM_004717
Nearest Ensembl:	ENSG00000157680
Gene Name:	cAMP responsive element binding protein 3 like 2
Gene Alias:	DGK-IOTA
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.181818
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CREB3L2 p2@CREB3L2 p3@CREB3L2 p4@CREB3L2 p5@CREB3L2 p6@CREB3L2 p8@CREB3L2 p9@CREB3L2
Sample		p1@CREB3L2	p2@CREB3L2	p3@CREB3L2	p4@CREB3L2	p5@CREB3L2	p6@CREB3L2	p8@CREB3L2	p9@CREB3L2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.16	3.70	0.00	0.00	0.39	0.39	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.69	2.83	0.00	0.00	0.00	1.62	0.20	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.87	3.09	0.00	0.00	0.39	0.39	1.54	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.28	1.87	0.00	0.00	0.21	0.42	0.62	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.82	1.80	0.00	0.00	0.22	0.67	0.90	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.11	1.36	0.00	0.00	0.39	1.74	0.58	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	8.50	2.61	0.00	0.00	0.44	0.22	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.30	3.88	0.00	0.00	0.48	0.48	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.12	2.14	0.00	0.00	0.00	0.64	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.11	1.74	0.00	0.00	0.00	0.58	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.53	4.45	0.00	0.00	0.00	2.02	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	4.07	0.00	0.00	0.41	1.63	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.86	6.61	0.00	0.00	0.64	1.29	0.64	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.08	3.31	0.00	0.00	0.30	1.20	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.20	4.39	0.00	0.00	0.88	1.10	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.33	5.03	0.00	0.25	0.00	2.51	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.98	4.15	0.00	0.44	0.44	2.62	0.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.55	2.53	0.00	0.00	0.00	3.37	3.80	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	2.13	0.00	0.00	0.53	1.60	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.89	5.42	0.00	0.00	1.20	2.11	1.50	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.44	6.01	0.00	0.00	0.67	2.00	1.47	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.57	4.14	0.17	0.00	0.69	2.07	0.69	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.80	5.82	0.13	0.00	0.52	1.03	1.29	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.07	5.34	0.00	0.24	0.00	4.13	1.46	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.83	4.13	0.00	0.00	0.00	2.32	1.81	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	3.17	0.32	0.00	0.63	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	3.85	0.55	0.00	2.75	3.85	2.20	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.10	4.95	0.00	0.00	1.18	0.71	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	17.44	3.07	0.00	0.00	1.29	2.10	1.13	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.81	4.71	0.00	0.18	0.90	1.81	0.54	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.73	3.14	0.00	0.00	1.05	3.14	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.78	2.93	0.00	0.00	1.37	3.32	1.17	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.36	4.22	0.00	0.21	1.06	3.38	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.26	5.11	0.00	0.00	2.80	5.44	3.96	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.56	4.11	0.19	0.00	1.31	4.67	2.80	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.76	6.13	0.00	0.00	2.87	1.72	1.92	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	26.77	4.29	0.00	0.00	1.43	5.11	2.04	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.99	5.64	0.00	0.00	1.61	2.42	2.42	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.53	6.21	0.27	0.00	2.70	3.51	1.62	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.17	4.56	0.00	0.00	1.44	2.64	2.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.82	3.76	0.00	0.00	3.06	4.71	0.94	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	27.67	5.12	0.00	0.15	2.64	5.56	2.93	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	31.21	5.69	0.00	0.00	1.90	5.06	1.90	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	32.17	6.99	0.17	0.17	3.15	3.50	1.57	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.12	4.62	0.00	0.00	3.21	2.41	1.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.36	4.65	0.00	0.23	2.79	7.68	2.56	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	30.47	6.72	0.00	0.00	2.40	5.04	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	27.72	5.66	0.00	0.00	1.79	3.58	1.79	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.81	6.22	0.00	0.00	4.07	4.55	2.63	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	37.20	5.46	0.20	0.00	4.65	4.45	2.83	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	48.37	8.61	0.00	0.00	6.15	10.66	5.33	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	60.04	9.34	0.00	0.00	6.45	12.23	7.56	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	13.99	0.00	0.00	41.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	53.58	12.07	0.00	0.00	4.61	3.19	4.26	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	51.03	11.27	0.00	0.00	4.97	6.63	3.31	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	5.87	0.00	0.00	8.39	37.75	5.87	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	40.41	11.02	0.00	0.00	2.76	15.61	5.97	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	46.35	9.72	0.00	0.00	4.54	6.48	2.59	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	42.72	16.38	0.00	0.00	4.82	3.53	2.57	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	64.44	11.00	0.00	0.00	4.71	19.49	6.29	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	9.17	0.00	0.00	1.41	4.23	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	38.69	10.65	0.00	0.00	2.24	4.49	2.24	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	42.99	15.13	0.00	0.00	2.39	43.79	6.37	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.05	13.59	0.00	0.00	2.38	12.57	3.74	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	38.02	10.07	0.00	0.00	1.95	2.92	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.88	10.65	0.00	0.00	1.42	3.55	2.48	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	15.79	0.00	0.00	15.79	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	37.05	12.68	0.00	0.00	3.41	3.41	2.93	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	25.79	10.91	0.00	0.00	2.98	3.47	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	8.91	0.00	0.00	1.41	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	32.79	8.61	0.00	0.00	1.32	5.63	2.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.01	12.37	0.00	0.00	2.47	4.02	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.07	7.64	0.00	0.00	2.14	2.14	0.61	1.22
Adipocyte - breast, donor1	11376-118A8	29.46	6.49	0.00	0.00	3.01	1.74	1.11	0.79
Adipocyte - breast, donor2	11327-117E4	22.46	6.10	0.00	0.00	2.25	3.53	1.93	0.96
Adipocyte - omental, donor1	11473-119C6	48.09	9.29	0.00	0.00	5.73	2.67	0.64	2.16
Adipocyte - omental, donor2	11474-119C7	10.46	4.48	0.00	0.00	0.75	1.49	0.75	1.49
Adipocyte - omental, donor3	11475-119C8	14.07	3.01	0.00	0.00	3.35	0.33	1.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	8.29	3.83	0.00	0.00	1.28	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	1.10	0.00	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	22.13	4.52	0.00	0.00	2.26	1.81	0.45	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	27.46	2.95	0.00	0.00	1.22	1.56	0.70	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	68.65	17.99	1.37	1.56	3.91	2.35	1.17	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	40.92	7.72	1.80	4.12	2.83	1.03	1.29	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	39.59	11.15	0.84	1.39	3.07	1.39	0.84	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	58.78	11.76	1.18	0.59	0.00	2.35	4.11	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	24.13	9.25	1.13	0.72	0.97	0.64	0.32	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	19.37	5.49	2.26	5.16	0.65	1.61	0.97	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	27.73	2.67	2.13	2.67	2.13	0.00	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	6.12	0.00	0.56	0.56	0.00	1.67	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	12.89	4.57	0.00	1.25	0.83	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	12.06	3.52	2.26	3.27	0.25	1.00	1.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	13.42	8.84	0.65	0.98	0.65	0.33	0.00	2.29
Adipocyte differentiation, day12, donor4	13030-139E6	9.13	2.74	0.30	0.00	0.30	0.61	0.61	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	33.59	9.28	0.00	0.00	1.33	1.33	1.33	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	7.17	3.94	0.00	0.00	1.79	0.00	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	7.19	0.00	0.00	1.20	2.40	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	39.22	20.51	0.00	0.00	1.08	1.80	1.44	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	51.88	15.06	0.00	0.00	1.67	6.69	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	44.79	14.18	0.00	0.00	1.44	0.82	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	62.59	9.84	0.00	0.00	4.23	4.92	2.52	0.92
Anulus Pulposus Cell, donor2	11463-119B5	27.43	5.39	0.00	0.00	3.43	1.22	0.24	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.67	4.04	0.00	0.90	3.59	6.74	4.49	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.82	3.91	0.00	0.00	0.87	2.17	2.17	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	6.42	0.00	0.00	2.14	6.42	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.90	5.38	0.00	1.20	0.60	4.48	2.39	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	2.53	0.00	0.00	2.53	1.26	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	21.78	3.96	0.00	0.00	1.98	7.26	3.96	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.49	6.50	0.32	0.65	1.62	4.87	1.95	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	21.84	5.34	0.00	0.00	0.97	3.40	3.40	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.76	2.97	0.00	0.00	0.00	4.75	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	21.47	6.78	0.00	0.00	3.01	5.27	3.77	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	27.58	2.18	0.00	0.00	2.18	6.53	2.18	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	6.27	0.00	0.00	0.00	10.03	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.01	6.59	0.00	0.00	1.32	0.99	0.82	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	5.46	0.00	0.00	0.00	4.09	6.82	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.70	6.03	0.00	0.00	1.36	1.81	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.65	4.29	0.00	0.00	3.21	5.89	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.18	3.02	0.00	0.00	1.89	2.08	3.40	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	39.83	5.88	0.00	0.00	1.34	3.47	2.67	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	27.31	3.90	0.00	0.00	0.98	5.85	4.88	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.71	5.31	0.00	0.00	1.66	2.49	2.16	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	6.00	0.00	0.00	1.20	2.40	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.88	3.95	0.00	0.00	2.40	4.63	1.54	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	4.19	0.00	0.00	0.00	12.58	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.08	2.91	0.00	0.00	1.46	3.88	1.94	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.08	4.55	0.00	0.00	0.38	3.04	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	3.63	0.00	0.00	1.21	4.85	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.10	2.85	0.00	0.00	1.71	7.98	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.95	5.34	0.00	0.00	1.50	4.28	1.71	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.42	3.87	0.00	0.00	0.52	3.10	1.29	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	4.22	0.00	0.00	1.88	1.88	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	4.82	0.00	0.00	1.29	2.89	1.93	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	7.13	0.00	0.00	0.00	1.43	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.04	2.92	0.00	0.00	1.17	3.51	2.34	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.16	3.91	0.00	0.00	0.90	3.91	3.61	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	3.56	0.00	0.00	0.00	4.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.85	4.07	0.00	0.00	1.53	3.56	3.56	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	25.47	6.62	0.00	0.00	1.02	3.31	1.27	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	5.08	0.00	0.00	0.00	2.54	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.87	4.32	0.00	0.00	0.00	4.75	2.59	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	20.96	3.39	0.00	0.00	1.06	2.96	1.06	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.04	3.19	0.00	0.00	0.00	2.61	1.16	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.01	4.72	0.00	0.00	2.83	4.72	5.67	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.22	4.41	0.00	0.00	1.53	3.22	1.53	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	9.27	0.00	0.00	0.00	2.32	6.95	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	8.45	0.00	0.00	4.23	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.02	4.07	0.00	0.00	2.36	4.07	2.14	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	5.41	0.00	0.00	1.80	6.02	3.61	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	23.33	1.46	0.00	0.00	1.46	2.92	2.92	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.13	4.37	0.00	0.00	2.07	3.68	2.07	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	2.55	0.00	0.00	0.00	7.65	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	23.14	4.07	0.00	0.00	1.78	1.02	1.02	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.44	4.54	0.00	0.00	1.65	5.57	1.24	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	29.38	4.28	0.00	0.00	1.22	5.20	2.14	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	37.28	6.21	0.00	0.00	0.96	6.69	5.26	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.83	5.10	0.00	0.00	2.88	6.43	3.77	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	7.63	0.00	0.00	0.00	1.53	4.58	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	30.46	4.43	0.00	0.00	1.66	3.32	2.77	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.01	3.44	0.00	0.00	2.65	3.97	3.18	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.53	6.91	0.00	0.00	1.82	1.82	3.63	1.45
Astrocyte - cerebellum, donor1	11500-119F6	23.34	9.21	0.00	0.00	3.19	1.60	0.25	0.98
Astrocyte - cerebellum, donor2	11580-120F5	28.75	10.27	0.00	0.00	3.77	2.05	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	19.51	4.19	0.00	0.00	1.26	0.42	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	13.25	9.06	0.00	0.00	0.70	1.05	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	22.81	9.38	0.00	0.00	0.65	0.97	1.13	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	36.69	7.16	0.00	0.00	1.79	2.83	0.89	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.17	36.01	11.01	12.39	0.34	2.87	0.80	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	39.96	35.71	12.40	11.28	1.00	2.26	0.88	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	46.09	35.85	11.95	11.27	0.46	1.14	1.02	0.23
Basophils, donor1	12241-129G9	6.54	10.72	6.54	6.02	0.00	0.52	0.00	0.26
Basophils, donor2	12242-129H1	5.77	11.55	15.51	14.79	0.00	0.36	0.36	0.00
Basophils, donor3	12243-129H2	8.82	9.70	6.47	5.73	0.15	0.15	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	14.45	8.84	0.00	0.00	0.43	1.51	0.65	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	5.49	5.03	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.06	9.57	0.00	0.00	0.21	0.21	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	9.67	0.00	0.00	0.46	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	13.14	9.54	0.00	0.00	0.00	1.98	1.26	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.16	5.46	0.00	0.00	0.00	0.21	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.26	5.36	0.00	0.00	0.23	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	22.70	10.23	15.99	13.43	0.64	1.28	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	31.03	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	4.51	8.45	1.69	5.07	0.00	0.00	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	3.90	5.38	3.71	8.17	0.00	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	4.17	9.66	3.95	4.83	0.00	1.54	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	7.08	13.30	35.95	31.42	0.00	0.85	1.70	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	8.72	14.78	32.22	18.57	0.00	1.90	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.90	15.45	42.08	36.82	0.00	0.00	0.99	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	5.06	5.93	7.37	9.54	0.00	1.16	1.45	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	7.54	3.32	4.22	7.24	0.00	1.21	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	5.45	8.29	4.50	7.34	0.00	0.71	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.35	4.18	2.34	5.52	0.00	0.50	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.76	3.04	3.04	3.04	0.28	0.28	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.22	2.48	2.23	3.47	0.00	1.49	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.98	2.74	2.15	6.85	0.00	0.78	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.27	2.14	3.56	5.16	0.18	0.89	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.09	1.96	3.70	4.57	0.00	0.65	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.04	2.34	3.04	5.85	0.00	0.47	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.64	5.28	4.22	7.39	0.00	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	4.44	5.55	9.98	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	3.42	4.02	8.48	0.00	1.04	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.79	3.99	3.39	4.99	0.00	0.40	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.54	5.20	1.87	3.12	0.00	0.83	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.49	3.66	4.12	7.55	0.00	0.46	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.39	5.43	3.62	5.43	0.00	0.23	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.06	3.49	2.18	3.49	0.00	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	2.96	2.96	6.99	0.00	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.14	7.33	2.97	5.76	0.17	0.87	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.52	3.79	4.63	4.21	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.92	2.20	2.02	4.96	0.00	0.37	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.47	3.17	2.82	1.41	0.00	1.41	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.63	3.07	1.75	4.39	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.44	2.62	3.49	7.67	0.00	1.05	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1.49	2.60	4.46	7.81	0.00	0.74	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.66	4.53	4.31	7.54	0.00	0.65	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.91	3.28	1.23	3.28	0.82	1.23	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.85	3.71	1.39	6.03	0.00	0.23	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.09	2.09	1.16	3.02	0.00	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	1.09	5.23	4.36	5.01	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	1.39	4.16	4.39	4.39	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.65	1.73	3.03	4.55	0.00	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	3.58	11.52	4.98	11.68	0.00	0.78	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	2.97	6.64	4.72	8.03	0.00	0.35	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	5.35	14.72	10.48	18.51	0.00	0.45	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.77	2.81	1.53	4.08	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.66	4.61	1.54	1.32	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	1.47	2.95	2.11	2.74	0.00	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	18.29	2.03	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	11.53	13.56	0.68	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	7.25	11.39	2.07	3.11	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	22.92	2.67	2.13	0.00	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	13.40	2.14	2.68	1.07	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	15.44	0.70	2.11	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.98	9.41	0.00	0.78	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5.27	14.50	1.32	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	26.30	21.37	4.11	2.47	0.00	0.00	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	10.16	11.61	1.45	1.45	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	11.11	12.62	2.02	3.53	0.00	1.51	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.06	6.06	0.81	1.21	0.81	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.19	7.59	0.80	2.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	25.10	4.02	9.04	12.05	3.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.36	1.12	2.25	2.81	1.12	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	20.29	18.79	6.01	6.39	0.00	1.13	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	20.29	18.49	12.40	10.82	0.23	0.68	0.23	0.45
CD4+ T Cells, donor1	11225-116C1	8.57	10.00	7.14	6.07	0.00	0.36	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	7.96	11.63	7.96	4.90	0.00	0.61	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	6.10	12.81	9.45	5.18	0.30	1.83	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.36	15.82	17.36	9.70	0.00	0.26	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	7.64	15.50	13.03	10.11	0.00	2.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.89	15.81	14.66	12.65	0.00	0.57	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	3.32	12.80	6.64	6.64	0.00	0.95	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	6.32	14.75	7.02	5.62	0.00	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	6.59	0.00	6.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.51	19.51	15.46	9.10	0.00	1.30	0.43	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.63	14.91	17.62	9.32	0.00	1.02	1.36	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	4.35	17.09	14.83	8.22	0.16	1.61	0.64	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	3.59	8.07	11.66	6.28	0.45	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	2.80	6.99	16.42	6.29	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3.52	13.20	18.92	7.92	0.00	1.76	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.75	20.24	8.85	9.70	0.00	0.00	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	10.80	30.13	8.10	6.23	0.21	2.08	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.68	22.72	7.35	6.35	0.33	2.67	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	7.34	1.90	3.81	0.00	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	6.43	6.43	2.14	3.75	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3.59	8.97	3.59	8.97	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	6.68	23.73	15.95	10.38	0.00	0.74	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.12	17.11	16.68	8.01	0.00	1.52	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	6.09	18.28	17.23	10.09	0.00	1.26	1.05	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.53	6.57	18.20	7.58	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	2.60	9.10	9.96	8.23	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.49	14.38	15.25	11.77	0.00	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1.98	7.42	11.38	5.94	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1.85	12.92	10.16	3.69	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	6.98	11.17	4.19	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2.22	13.57	12.18	7.48	0.00	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2.94	14.72	19.14	11.04	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	7.70	15.40	9.24	6.16	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2.15	13.61	13.61	8.24	0.00	0.72	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	6.92	13.85	22.16	8.31	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	15.71	19.64	16.04	6.88	0.00	0.65	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	6.38	15.02	11.26	6.38	0.00	1.50	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	12.88	9.59	9.85	6.06	0.25	2.78	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.53	11.47	0.00	0.23	0.23	1.15	1.61	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.06	11.98	0.24	0.24	0.48	1.92	1.20	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.77	9.58	0.82	1.09	0.55	1.92	1.37	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.01	11.41	0.60	1.50	0.30	3.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.60	11.04	0.00	1.20	0.24	2.40	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.64	10.23	0.45	0.68	0.45	2.96	0.91	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.47	7.60	0.00	0.65	0.00	1.09	0.22	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.58	9.48	0.00	1.05	0.26	2.11	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.74	8.44	0.23	0.23	0.23	0.94	0.70	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.66	9.66	0.00	0.60	0.00	0.60	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.62	8.72	0.00	0.00	0.00	2.32	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.79	10.92	0.00	0.27	0.27	1.07	0.27	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.95	11.38	0.44	0.44	3.06	1.75	0.44	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.58	6.83	0.46	0.46	0.46	0.91	0.46	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	8.20	0.00	0.75	2.98	1.49	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.49	9.00	0.72	0.72	0.72	2.16	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.67	6.91	0.86	0.58	0.58	2.88	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.56	9.19	0.24	2.12	0.00	1.89	0.71	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.46	10.46	0.00	0.00	0.63	1.58	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.99	9.53	0.31	0.31	0.00	2.77	0.92	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.62	9.30	0.00	0.32	0.00	2.24	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	10.71	12.24	0.38	0.00	0.00	2.68	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	8.28	0.00	0.00	0.00	1.58	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	10.59	0.00	0.00	0.00	1.51	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	11.24	0.00	1.61	4.01	2.41	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.29	9.79	0.00	0.70	2.80	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	11.02	0.00	0.00	2.00	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	0.00	0.00	0.00	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.35	4.94	0.00	0.00	0.00	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	12.84	5.89	0.00	0.00	0.32	0.74	0.32	0.21
Chondrocyte - de diff, donor1	11261-116G1	29.12	5.89	0.35	0.35	3.12	2.43	2.43	1.73
Chondrocyte - de diff, donor2	11338-117F6	24.17	8.53	0.00	0.00	2.49	0.71	1.07	0.71
Chondrocyte - de diff, donor3	11410-118E6	29.47	5.69	0.23	0.00	1.59	4.44	2.73	0.23
Chondrocyte - re diff, donor2	11339-117F7	60.88	17.91	0.00	0.00	5.37	1.79	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	118.89	15.77	0.40	0.00	8.49	5.26	2.43	4.45
Ciliary Epithelial Cells, donor1	11242-116D9	39.36	11.25	0.23	0.11	1.61	2.30	1.95	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	40.19	11.54	0.00	0.00	1.28	3.85	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	49.29	10.27	0.27	0.27	3.10	3.45	1.86	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	43.28	21.09	1.47	3.12	2.66	1.10	0.18	1.56
Corneal Epithelial Cells, donor1	11526-119I5	11.64	9.66	0.00	0.00	0.66	0.88	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	5.69	0.00	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	10.99	5.62	0.00	0.00	0.00	0.00	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	2.64	8.42	2.81	3.47	0.33	0.66	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.05	7.57	2.84	4.10	0.00	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.46	6.59	2.70	5.29	0.00	0.43	0.54	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	129.82	52.27	1.02	1.37	1.71	4.44	1.71	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	107.72	40.48	0.65	0.65	1.31	1.96	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	86.14	36.30	0.97	0.00	3.87	0.48	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	18.68	7.17	0.00	0.00	0.33	0.17	0.17	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	2.93	0.00	0.00	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	29.69	8.77	0.28	0.00	0.85	0.57	0.00	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	25.56	4.72	0.00	0.00	0.39	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	23.27	5.82	0.00	0.00	1.16	0.00	0.00	2.04
Endothelial Cells - Artery, donor2	11341-117F9	38.12	7.76	0.47	0.00	1.18	2.35	1.88	0.71
Endothelial Cells - Artery, donor3	11413-118E9	23.14	8.06	0.00	0.00	0.88	1.23	0.18	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.50	7.31	0.00	0.22	0.89	1.11	0.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.86	11.87	0.00	0.00	0.30	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	41.72	13.53	0.00	0.00	1.13	1.41	1.13	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	12.18	5.35	0.00	0.00	0.89	1.19	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	17.70	1.56	0.00	0.00	0.52	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	16.16	5.53	0.00	0.00	0.71	0.85	0.85	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	22.81	5.60	0.00	0.00	0.80	1.20	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	21.49	5.24	0.00	0.00	0.52	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	63.86	14.04	0.25	0.00	1.12	1.99	2.36	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	58.66	12.38	0.22	0.00	1.30	0.43	0.87	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	57.16	17.95	0.00	0.00	1.22	1.22	1.10	1.34
Endothelial Cells - Vein, donor1	11267-116G7	22.75	4.55	0.00	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	21.65	4.89	1.40	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	27.48	6.44	0.00	0.00	0.63	0.79	0.00	0.94
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	4.95	6.60	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	3.57	10.70	3.57	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	11.97	0.00	0.00	1.22	0.98	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	41.05	8.21	0.00	0.00	2.46	3.69	1.23	4.11
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.13	2.85	0.00	0.00	0.22	1.20	0.55	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.97	3.03	0.00	0.00	0.33	2.60	1.30	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.47	8.00	0.00	0.00	1.33	2.43	1.21	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.15	10.37	0.00	0.00	3.41	0.68	0.68	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.14	5.80	0.00	0.00	1.27	2.00	1.05	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.41	12.65	0.00	0.00	4.74	1.84	0.26	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	34.22	10.30	0.00	0.33	1.99	4.32	2.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	14.97	3.18	0.00	0.00	0.91	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	24.25	8.34	0.00	0.00	1.52	1.52	0.76	2.27
Fibroblast - Cardiac, donor3	11417-118F4	30.75	5.99	0.00	0.00	1.42	0.95	0.63	1.26
Fibroblast - Cardiac, donor4	11452-119A3	25.76	10.91	0.00	0.00	0.61	0.30	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	20.05	8.50	0.00	0.00	0.38	0.63	0.63	0.51
Fibroblast - Cardiac, donor6	11460-119B2	13.19	8.34	0.00	0.00	0.91	0.45	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.31	6.97	0.00	0.00	5.09	1.07	0.54	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	95.35	5.61	0.00	0.00	7.77	5.18	0.86	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	65.92	16.11	0.00	0.00	5.86	1.46	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	42.44	14.53	0.00	0.00	1.15	1.15	1.38	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	26.29	6.78	0.00	0.00	1.19	1.53	0.17	0.68
Fibroblast - Dermal, donor1	11269-116G9	25.59	5.17	0.00	0.00	1.41	1.41	0.47	1.17
Fibroblast - Dermal, donor2	11346-117G5	19.34	4.72	0.00	0.00	0.47	0.00	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	27.08	5.32	0.00	0.00	1.45	2.18	2.42	0.85
Fibroblast - Dermal, donor4	11450-119A1	25.55	10.40	0.00	0.00	0.79	0.79	0.45	0.23
Fibroblast - Dermal, donor5	11454-119A5	27.21	9.42	0.00	0.00	1.05	0.70	0.52	0.87
Fibroblast - Dermal, donor6	11458-119A9	33.13	10.40	0.00	0.00	1.14	1.14	0.32	0.65
Fibroblast - Gingival, donor1	11237-116D4	58.93	9.79	0.00	0.00	2.29	2.29	2.08	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	110.04	13.89	0.00	0.00	11.79	2.10	2.36	2.62
Fibroblast - Gingival, donor2	11318-117D4	42.57	13.05	0.00	0.00	0.79	3.69	2.11	0.92
Fibroblast - Gingival, donor3	11394-118C8	53.95	12.96	0.00	0.00	1.45	1.55	2.03	1.55
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	5.19	0.00	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.78	7.22	0.00	0.00	0.88	1.76	2.29	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.68	13.41	0.00	0.00	4.52	2.49	0.94	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	53.82	11.09	0.00	0.00	2.70	1.89	1.35	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	95.63	22.58	0.00	0.00	9.17	0.35	0.71	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.38	8.92	0.00	0.00	2.63	1.90	1.02	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	71.99	9.82	0.00	0.00	6.27	2.32	0.41	2.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	65.38	15.25	0.00	0.00	4.28	2.30	0.99	2.08
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.84	16.43	0.00	0.00	1.47	1.61	0.29	1.03
Fibroblast - Lung, donor1	11270-116H1	21.75	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	65.65	13.43	0.00	0.00	0.00	2.98	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	62.47	10.55	0.00	0.00	3.80	4.43	2.11	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	43.32	24.99	0.00	0.00	4.17	0.00	0.00	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	4.20	0.00	0.00	4.20	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.47	3.08	0.00	0.00	0.00	0.28	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	99.87	30.04	0.81	0.00	3.25	1.62	0.00	2.03
Fibroblast - Mammary, donor2	11620-122A9	15.98	11.98	0.00	0.00	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.82	11.64	0.00	0.00	1.16	2.52	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	75.99	20.17	0.00	0.00	1.37	2.73	0.30	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	91.80	21.73	0.00	0.00	6.43	2.45	0.31	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	45.03	4.96	0.00	0.00	3.05	0.76	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	23.76	7.56	0.00	0.00	1.35	1.08	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.07	11.25	0.00	0.00	2.55	1.74	0.81	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.90	6.30	0.00	0.00	0.77	1.77	1.99	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	83.92	23.16	0.20	0.20	3.66	2.44	1.63	1.83
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	40.09	8.69	0.00	0.00	0.67	1.34	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	21.74	3.95	0.00	0.00	2.37	1.98	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	63.30	18.65	0.00	0.00	7.14	0.79	0.79	2.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	20.43	7.82	0.00	0.00	0.71	0.71	1.07	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.83	6.31	0.00	0.00	1.58	1.58	1.97	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	84.24	6.32	0.00	0.00	16.25	1.50	0.60	4.21
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	45.99	11.12	0.00	0.00	6.48	1.84	1.08	2.05
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	31.38	12.65	0.00	0.00	4.05	1.01	0.25	2.53
Fibroblast - skin normal, donor1	11553-120C5	26.58	4.76	0.00	0.00	1.31	2.30	0.49	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	98.65	19.85	0.00	0.00	15.44	4.21	1.20	3.81
Fibroblast - skin normal, donor2	11561-120D4	26.02	9.64	0.00	0.00	3.01	0.80	0.90	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.00	19.34	0.00	0.00	14.51	2.72	0.91	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	30.49	8.95	0.00	0.00	1.08	2.73	0.66	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.17	10.43	0.00	0.00	0.68	1.03	0.51	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	69.63	12.48	0.00	0.00	11.50	3.28	0.33	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	37.71	12.78	0.00	0.00	6.92	1.70	0.21	1.92
Fibroblast - skin walker warburg, donor1	11554-120C6	43.86	9.78	0.00	0.00	3.54	4.22	1.69	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.11	7.06	0.00	0.00	0.94	5.65	2.51	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	0.00	66.48	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	6.10	0.00	0.00	0.00	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.22	9.19	0.00	0.00	0.52	1.91	0.52	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	33.57	19.52	0.00	0.00	0.26	1.56	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.06	8.43	0.00	0.00	0.51	0.26	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	24.50	2.30	0.00	0.00	0.00	3.06	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.68	1.28	0.00	0.00	0.00	2.55	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	37.08	5.99	0.00	0.00	0.86	5.13	3.99	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	14.89	8.00	0.00	0.00	0.28	2.21	1.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	17.12	6.16	0.00	0.00	0.46	3.42	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	30.12	6.54	0.00	0.00	1.19	6.34	1.19	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	17.18	7.93	0.00	0.00	0.00	4.49	1.85	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	24.79	6.20	0.00	0.00	0.00	2.94	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	22.55	6.63	0.00	0.00	1.77	5.31	3.54	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.83	7.77	0.00	0.00	0.71	1.70	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	31.40	6.03	0.00	0.00	0.62	0.99	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.03	4.03	0.00	0.00	0.00	2.15	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.35	7.81	0.00	0.00	0.62	0.99	1.24	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.67	7.48	0.00	0.00	0.28	0.55	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.92	6.91	0.20	0.00	0.00	2.24	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	25.56	8.67	0.00	0.00	1.14	2.28	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.18	6.85	0.12	0.00	0.12	0.87	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.29	10.93	0.00	0.00	0.66	1.97	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	26.59	10.34	0.00	0.00	0.00	2.36	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.75	9.38	0.00	0.00	0.48	1.59	0.95	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.16	10.72	0.00	0.00	0.45	1.34	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.81	9.48	0.00	0.81	0.60	2.02	1.61	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.54	9.50	0.00	0.00	0.17	1.02	1.19	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	42.47	13.30	0.53	0.35	1.06	2.39	0.53	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.94	21.54	0.42	1.04	0.31	2.39	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.25	15.54	0.34	0.51	0.51	0.85	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.89	9.96	0.11	0.00	0.44	1.66	0.89	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.52	13.64	0.25	0.75	1.33	2.16	1.33	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.55	9.39	0.20	0.61	0.20	1.02	0.00	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	25.17	6.60	0.21	0.00	0.21	1.65	1.03	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	27.67	13.60	0.12	0.12	0.35	1.73	1.04	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	40.02	14.01	0.50	1.00	0.83	1.83	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.47	9.92	0.00	0.22	0.00	2.87	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	25.46	9.59	0.12	0.12	0.74	1.60	0.86	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.44	11.02	0.97	0.97	0.49	1.62	0.97	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.26	9.94	0.00	0.00	0.00	2.57	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.28	9.66	0.00	0.09	0.19	1.23	0.66	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.42	12.18	0.47	0.63	0.47	1.90	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.59	10.64	0.30	0.61	0.30	1.52	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.64	9.72	0.00	0.31	0.42	1.67	0.84	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.98	9.22	0.44	1.54	0.22	2.20	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.04	8.70	0.00	0.00	0.28	3.37	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.81	10.83	0.00	0.19	0.46	1.30	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.68	9.63	0.27	1.60	0.00	0.80	1.60	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.84	12.55	1.07	1.07	0.61	2.60	0.92	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.15	9.72	0.13	0.13	0.00	0.91	0.39	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.65	9.76	0.54	1.63	0.54	1.63	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.84	9.95	0.37	0.37	0.37	2.21	1.29	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.98	11.62	0.00	0.22	1.10	1.97	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	61.49	25.79	0.00	0.00	1.98	3.97	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	38.52	11.48	0.13	0.13	0.79	1.58	0.92	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.48	13.52	0.00	0.00	0.61	2.22	1.21	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	115.64	40.41	0.25	0.00	1.02	3.05	0.76	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	18.51	8.36	0.00	0.00	1.00	0.20	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	23.11	8.78	0.00	0.00	0.92	0.62	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	31.71	8.39	0.00	0.00	1.02	1.84	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.27	3.44	0.00	0.00	0.31	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.32	1.98	0.00	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.06	3.23	0.00	0.00	0.00	2.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	4.95	0.00	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	24.37	3.48	0.00	0.00	0.77	1.16	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	4.81	0.00	0.00	1.60	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	26.08	1.74	0.00	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	21.16	3.91	0.00	0.00	0.98	1.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.47	1.24	0.00	0.00	1.24	0.82	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	0.00	0.00	0.00	6.66	10.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	31.04	4.19	0.00	0.00	1.12	2.24	1.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	38.24	4.25	0.00	0.00	0.65	2.29	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	6.71	0.00	0.00	0.00	5.03	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.53	8.27	0.00	0.00	0.64	2.86	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	28.53	5.43	0.00	0.00	1.70	1.70	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	10.44	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.78	9.74	0.00	0.00	0.57	3.44	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.45	5.03	0.00	0.00	1.48	4.14	2.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	6.78	0.00	0.00	0.00	1.69	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	52.60	7.46	0.00	0.00	1.24	4.56	2.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	37.05	5.52	0.00	0.00	0.69	3.68	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	5.27	0.00	0.00	5.27	21.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	48.05	5.77	0.00	0.00	1.92	4.61	2.69	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	52.48	6.52	0.00	0.00	1.30	3.59	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	37.46	4.68	0.00	0.00	0.00	2.68	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.95	12.33	0.00	0.00	0.39	2.31	2.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	93.12	7.53	0.00	0.00	3.77	4.11	2.74	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	17.39	0.00	0.00	0.00	7.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	48.13	11.32	0.00	0.00	2.36	2.83	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	45.26	9.66	0.00	0.00	0.60	6.64	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	41.20	10.68	0.00	0.00	0.51	3.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.06	11.57	0.00	0.00	0.40	3.59	4.79	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	56.24	9.87	0.00	0.00	1.97	4.44	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	59.02	14.17	0.00	0.00	3.54	9.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	51.34	7.58	0.00	0.00	0.58	3.50	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	49.59	13.17	0.00	0.00	1.32	4.83	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	60.19	7.63	0.00	0.00	0.85	5.93	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.83	6.57	0.00	0.00	0.60	4.18	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	38.82	8.73	0.00	0.00	0.97	1.46	2.43	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	41.09	6.85	0.00	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.52	5.41	0.00	0.00	1.25	5.41	1.25	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	5.62	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.74	7.93	0.00	0.00	0.32	3.17	1.59	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	2.92	0.00	0.00	1.25	1.25	1.67	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	19.15	7.31	0.00	0.00	0.93	1.97	1.28	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.11	6.58	0.00	0.00	1.01	1.86	1.18	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.16	5.69	0.00	0.00	1.37	2.05	1.14	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.46	5.03	0.00	0.00	0.98	2.40	1.09	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.13	5.80	0.00	0.00	0.64	1.93	1.07	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.73	7.32	0.00	0.00	0.65	1.51	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.31	5.36	0.00	0.00	0.75	1.99	1.99	1.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	17.67	5.66	0.00	0.00	0.17	2.40	1.37	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.02	2.88	0.00	0.00	0.32	1.28	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	6.72	0.56	0.00	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.76	9.52	0.00	0.00	0.43	2.16	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	2.64	0.00	0.00	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.92	13.05	0.00	0.00	1.41	0.35	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	19.62	10.17	0.00	0.00	3.63	2.91	2.18	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	26.40	5.94	0.00	0.00	1.05	2.27	2.10	0.35
Hepatocyte, donor1	11523-119I2	31.48	6.05	0.00	0.00	2.42	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	6.46	6.46	2.15	0.00	0.00	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	22.09	10.43	0.00	0.61	0.61	3.07	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	6.53	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	58.73	24.64	0.17	0.17	2.10	4.72	2.45	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.13	7.68	0.14	0.00	0.14	1.51	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	19.10	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	20.77	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	15.02	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	17.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	22.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	32.49	21.12	3.25	3.25	1.62	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	10.00	0.00	1.67	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	14.52	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	43.67	23.82	0.00	2.65	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	12.20	1.11	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	10.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.82	18.90	0.00	2.52	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	10.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	18.09	2.58	0.65	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	17.71	1.61	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	23.90	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	24.45	9.78	2.44	0.00	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.75	14.69	0.42	1.68	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	38.58	16.88	1.61	0.80	0.80	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	22.16	6.46	0.92	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	18.88	12.27	0.94	1.42	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	9.07	0.91	0.00	1.81	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	44.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	43.04	9.69	1.08	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	45.74	16.52	1.27	2.54	1.27	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	32.52	26.14	1.28	1.91	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	16.40	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	49.27	17.14	1.43	0.71	0.00	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	16.59	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	33.64	13.27	0.31	0.62	0.00	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	14.05	1.76	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	3.14	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	43.11	13.21	0.00	2.09	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	13.28	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	29.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	17.44	3.49	0.00	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	40.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	13.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	29.87	13.87	0.00	1.07	1.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	20.78	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	8.55	2.85	2.85	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	26.69	11.97	0.92	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	15.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	24.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	21.15	1.06	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.61	6.12	0.00	0.00	0.24	1.71	0.49	0.33
Keratinocyte - epidermal, donor2	11349-117G8	5.27	3.51	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	14.39	11.64	0.00	0.00	0.28	1.14	0.66	0.38
Keratinocyte - oral, donor1	11251-116E9	23.73	16.80	0.00	0.00	0.34	2.50	2.27	0.11
Keratocytes, donor1	11527-119I6	48.48	18.91	0.00	0.00	1.38	2.41	3.09	0.69
Keratocytes, donor2	11607-120I5	48.04	7.03	0.00	0.00	0.00	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	37.74	11.26	0.00	0.00	0.40	3.36	0.79	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	13.19	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	21.57	6.47	0.00	0.00	0.00	3.24	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	12.80	6.46	0.12	0.00	0.58	1.15	0.46	0.35
Lens Epithelial Cells, donor3	11690-122I7	57.22	12.61	0.00	0.00	3.53	2.83	0.71	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.86	7.47	0.12	0.00	0.24	0.59	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	4.74	0.00	0.00	0.00	0.84	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.34	8.34	0.00	0.00	0.16	1.57	0.63	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	1.61	0.00	0.00	0.00	0.00	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	9.45	6.62	0.00	0.00	0.32	1.26	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.76	4.53	0.00	0.00	0.32	0.97	0.75	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	3.28	0.00	0.00	0.00	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.85	2.53	0.00	0.25	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.57	3.10	0.14	0.00	0.00	0.99	0.70	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.49	3.56	0.00	0.00	0.40	3.16	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.11	4.65	0.00	0.00	0.00	1.36	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	2.41	0.00	0.00	0.19	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	3.14	0.00	0.00	0.70	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.59	6.44	0.00	0.00	0.24	0.95	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.73	4.53	0.00	0.00	0.00	1.37	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.01	2.77	0.00	0.00	0.62	2.16	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.55	4.36	0.31	0.00	0.00	0.31	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.97	4.94	0.00	0.00	0.18	0.73	0.73	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.56	3.29	0.00	0.00	0.33	2.63	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.32	3.22	0.00	0.00	0.00	0.00	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.71	3.24	0.00	0.00	0.00	1.24	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	1.94	0.00	0.00	0.00	1.94	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	4.31	0.00	0.00	0.54	1.35	1.62	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.02	4.09	0.00	0.15	0.00	0.91	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	3.63	0.00	0.00	0.00	1.56	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.94	6.07	0.00	0.00	0.21	1.26	1.47	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.86	4.96	0.00	0.00	0.30	1.05	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	10.32	0.00	0.00	0.00	2.06	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.41	4.52	0.00	0.00	0.00	0.56	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.74	4.24	0.00	0.00	0.11	1.06	1.06	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.18	4.85	0.00	0.00	0.00	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	2.98	0.00	0.00	0.33	1.32	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.55	3.84	0.00	0.12	0.00	0.50	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.11	3.33	0.00	0.00	0.00	0.37	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.65	3.71	0.00	0.25	0.25	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.29	3.57	0.14	0.00	0.00	0.41	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.75	4.50	0.00	0.00	0.64	0.32	1.29	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.56	6.70	0.00	0.00	0.61	0.61	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.66	5.74	0.00	0.00	0.28	0.98	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.60	3.91	0.00	0.00	0.00	1.42	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	3.88	0.00	0.00	0.48	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.14	3.27	0.00	0.00	0.47	0.93	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.88	3.22	0.00	0.00	0.00	1.43	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.80	4.57	0.00	0.00	0.65	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.18	3.53	0.00	0.00	0.24	0.47	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.77	6.31	0.00	0.00	0.25	0.74	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.96	2.31	0.00	0.00	0.26	0.77	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.76	3.88	0.00	0.00	0.30	0.90	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.07	6.90	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	7.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.65	7.19	0.00	0.00	0.42	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	6.33	0.00	0.00	0.70	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	4.67	0.00	0.00	0.00	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	10.31	0.00	0.00	0.00	1.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	2.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.20	5.20	0.00	0.00	0.23	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.23	5.53	0.00	0.00	0.00	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.60	4.05	0.00	0.00	0.90	3.60	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.59	8.94	0.00	0.00	0.14	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	6.16	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.00	6.70	0.00	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.00	4.00	0.00	0.00	0.00	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.13	6.11	0.00	0.00	0.00	2.04	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5.07	6.14	0.00	0.00	0.27	0.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	7.37	5.86	0.00	0.00	0.38	0.38	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	4.29	0.00	0.00	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.15	8.15	0.00	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	6.66	6.87	0.00	0.00	0.42	0.83	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	4.48	5.61	0.00	0.00	0.28	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	4.12	8.24	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	5.23	7.26	0.00	0.00	0.87	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.88	4.78	0.00	0.00	0.00	2.09	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.62	5.53	0.00	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.01	6.72	0.00	0.00	0.35	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.06	8.85	0.00	0.00	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	9.21	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.52	5.76	0.00	0.00	0.38	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.36	9.06	0.00	0.00	0.00	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	7.38	0.00	0.00	0.00	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.68	4.97	0.00	0.00	0.00	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	7.18	0.00	0.00	0.72	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.23	7.47	0.00	0.00	0.00	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.57	9.29	0.00	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5.17	5.60	0.00	0.00	0.00	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	5.99	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6.33	9.00	0.00	0.00	0.00	1.00	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	5.43	4.22	0.00	0.00	0.00	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	7.11	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5.16	7.91	0.00	0.00	0.34	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	3.22	5.90	0.00	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.02	6.06	0.00	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.56	8.52	0.00	0.00	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	6.98	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	5.29	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	7.20	0.00	0.00	0.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	7.27	0.00	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	8.43	8.43	0.00	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	8.88	0.00	0.00	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	1.88	0.00	0.00	0.94	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.52	7.54	0.00	0.00	0.00	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.96	5.86	0.00	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	1.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	4.90	6.23	0.00	0.00	0.00	1.34	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	3.52	0.00	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	4.62	3.30	0.00	0.00	0.00	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	5.19	4.67	0.00	0.00	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.81	3.50	0.00	0.00	0.00	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2.24	9.50	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	3.09	3.97	0.00	0.00	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.17	6.17	0.00	0.00	0.39	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	4.05	3.54	0.00	0.00	0.00	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	6.73	5.29	0.00	0.00	0.96	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	6.36	7.95	0.00	0.00	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	3.04	3.04	0.00	0.00	1.22	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.92	5.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.46	6.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	3.61	0.52	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.05	5.44	0.00	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	6.34	5.70	0.00	0.00	0.00	0.95	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.86	5.33	0.00	0.00	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.02	5.75	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	7.71	0.00	0.00	0.00	1.03	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	8.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	3.40	5.67	0.00	0.00	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	6.24	7.07	0.00	0.00	0.83	0.83	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.92	5.48	0.00	0.00	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1.25	8.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.97	7.43	0.00	0.00	0.46	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	6.02	0.00	0.00	0.00	0.67	0.00	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2.67	2.14	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.47	8.89	0.00	0.00	0.00	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	3.67	0.00	0.00	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	7.11	0.00	0.00	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	7.41	0.00	0.00	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.07	5.37	0.00	0.00	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2.19	6.02	0.00	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.35	8.46	0.00	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	5.98	10.92	0.00	0.00	0.00	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2.65	6.63	0.00	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	12.47	0.00	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	2.96	4.79	31.68	28.03	0.00	1.37	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.06	8.44	15.05	20.00	0.00	0.73	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	6.82	8.26	20.32	25.95	0.00	2.10	1.18	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	5.84	0.00	0.00	0.00	0.53	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	30.26	11.09	0.00	0.00	1.11	1.58	0.95	0.48
Mallassez-derived cells, donor3	11930-125I4	22.10	6.39	0.14	0.00	0.83	2.22	0.28	0.69
Mammary Epithelial Cell, donor1	11273-116H4	30.39	16.94	0.70	0.50	0.90	3.19	1.49	0.50
Mammary Epithelial Cell, donor2	11350-117G9	22.30	9.27	1.16	1.16	1.16	1.16	1.16	0.87
Mammary Epithelial Cell, donor3	11422-118F9	9.48	3.74	0.50	0.50	0.25	0.75	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	744.37	124.06	160.67	154.57	41.35	1.36	6.10	4.75
Mast cell, donor1	11563-120D6	148.15	42.17	51.48	36.23	4.54	6.49	2.81	1.62
Mast cell, donor2	11565-120D8	248.44	87.96	13.97	10.70	11.29	3.86	0.00	2.97
Mast cell, donor3	11566-120D9	250.34	104.91	15.53	15.76	9.68	7.88	4.05	6.98
Mast cell, donor4	11567-120E1	208.31	86.34	16.31	12.41	10.81	2.48	0.71	2.48
Mast cell, expanded and stimulated, donor5	11940-126A5	199.39	68.98	53.34	47.57	4.88	13.53	4.77	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	152.92	46.69	26.27	33.85	1.17	9.92	1.17	3.50
Mast cell, expanded, donor5	11939-126A4	98.78	35.68	54.49	37.86	1.38	4.47	2.18	0.34
Mast cell, expanded, donor8	11941-126A6	96.91	34.31	36.32	32.64	2.18	3.51	0.50	1.34
Melanocyte - dark, donor1	11502-119F8	16.62	9.25	0.00	0.00	0.40	0.90	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	13.84	5.19	0.00	0.00	0.00	1.04	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	15.79	15.36	0.29	1.45	0.22	1.38	0.43	0.58
Melanocyte - light, donor1	11274-116H5	22.33	13.87	0.00	0.94	0.47	0.47	0.24	0.24
Melanocyte - light, donor2	11351-117H1	8.19	8.87	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.88	4.34	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	26.03	10.72	0.10	0.31	0.21	1.25	1.35	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	22.32	9.14	1.08	1.34	0.00	2.42	1.08	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	16.61	8.84	0.27	0.00	0.27	2.68	1.07	0.54
Meningeal Cells, donor1	11493-119E8	54.83	20.59	0.00	0.00	2.61	1.24	0.50	1.98
Meningeal Cells, donor2	11573-120E7	22.01	5.28	0.00	0.00	3.52	0.44	0.44	0.44
Meningeal Cells, donor3	11654-122E7	66.18	11.08	0.00	0.00	2.36	4.48	2.04	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.34	6.84	0.00	0.00	2.00	3.14	2.28	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	47.80	10.57	0.00	0.00	5.43	1.71	1.41	1.71
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	6.54	0.00	0.00	3.92	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	42.34	10.76	0.00	0.00	2.87	2.15	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.18	5.08	0.00	0.00	2.12	2.75	1.06	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.09	2.51	0.00	0.00	0.00	1.01	1.51	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	39.78	12.09	0.44	0.00	2.42	1.76	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	37.99	6.58	0.00	0.00	3.65	0.00	3.65	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	43.99	8.80	0.20	0.41	3.48	0.82	0.61	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.80	8.17	0.00	0.00	0.42	0.97	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.07	5.20	0.00	0.00	1.12	0.74	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.05	7.50	0.00	0.00	2.24	2.50	1.58	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	43.32	5.64	0.00	0.00	2.97	2.37	2.08	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	39.70	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.30	7.04	0.00	0.00	1.92	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	33.32	10.99	0.00	0.35	0.71	2.48	2.13	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	43.47	5.32	0.00	0.00	2.81	3.13	0.94	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	5.08	0.00	0.00	1.45	2.90	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	12.46	8.49	0.00	0.00	0.80	0.80	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	13.51	4.00	0.00	0.00	0.50	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.56	8.67	0.07	0.00	0.14	1.37	0.65	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	16.20	51.31	64.82	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	7.39	29.55	32.75	0.25	2.71	0.99	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	8.54	22.97	27.68	0.00	1.47	0.88	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	6.91	13.83	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.65	4.96	20.15	22.01	0.00	1.86	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.02	7.26	18.25	24.27	0.00	1.04	0.83	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	11.58	13.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	4.00	5.76	22.52	23.77	0.00	2.75	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	8.84	28.39	27.93	0.00	0.93	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.69	4.27	19.10	25.00	0.20	2.44	1.63	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.73	4.75	18.61	22.57	0.00	1.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	8.55	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	2.65	14.16	21.24	0.00	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	3.04	18.62	26.60	0.00	1.90	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	2.63	11.84	10.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.73	2.97	18.25	19.74	0.00	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	1.84	16.57	19.34	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.15	2.98	12.52	16.99	0.00	1.79	0.89	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	13.41	15.09	0.00	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.51	2.76	15.31	15.56	0.00	0.75	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.57	1.90	13.55	19.25	0.00	1.19	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	2.76	2.76	7.74	0.00	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.68	1.15	11.05	14.74	0.00	2.53	1.15	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.94	4.84	13.25	14.93	0.00	0.42	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.30	2.65	10.80	15.29	0.00	0.61	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.86	2.36	14.59	15.88	0.21	2.57	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.45	4.00	11.11	13.34	0.22	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.41	1.53	8.54	12.92	0.00	1.53	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	4.06	7.60	15.72	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	3.31	0.00	4.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.89	0.82	5.44	10.87	0.00	0.54	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.53	1.18	8.82	15.00	0.00	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	5.45	1.09	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.40	2.40	2.88	5.29	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.20	2.00	3.20	13.21	0.00	2.00	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	1.37	5.48	4.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	2.00	3.50	3.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	2.04	4.08	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	2.19	1.31	10.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	2.21	6.62	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	1.28	2.56	5.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.99	0.99	2.23	8.18	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.70	3.48	9.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	8.84	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.68	0.34	7.18	16.07	0.00	2.05	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.31	1.31	5.25	15.32	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	1.07	5.33	9.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.84	1.40	7.86	15.43	0.00	1.68	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.42	1.66	4.16	12.05	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.58	7.58	10.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.90	0.60	4.22	12.37	0.00	1.81	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.42	1.25	11.27	18.37	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	1.85	5.54	18.47	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.71	1.71	9.11	31.30	0.00	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1.38	2.07	7.88	15.48	0.00	0.55	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.26	0.78	7.52	23.84	0.00	0.78	1.30	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.72	3.00	12.01	21.88	0.00	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	2.54	5.08	12.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.53	1.07	6.41	16.01	0.00	1.87	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1.20	2.69	13.17	25.44	0.00	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.42	1.98	6.92	16.95	0.00	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.32	0.32	7.01	20.70	0.00	1.91	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.65	2.43	8.85	27.86	0.00	0.66	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.90	2.65	5.31	17.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.28	2.56	7.95	21.02	0.00	1.99	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.97	1.97	9.09	28.51	0.00	1.47	1.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.96	1.30	5.21	14.99	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1.76	1.18	4.41	22.35	0.00	1.76	1.47	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	2.02	1.73	9.80	25.66	0.00	1.73	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	3.30	3.30	16.07	46.16	0.00	2.06	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1.19	2.68	8.34	25.01	0.30	0.89	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	22.60	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	14.26	8.91	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2.96	1.64	23.66	20.04	0.00	2.63	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	3.16	13.68	15.78	0.00	2.10	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.16	5.93	17.40	20.56	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	4.66	18.63	22.35	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.01	4.88	27.04	17.65	0.00	3.76	1.88	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.33	4.79	13.85	11.45	0.00	1.07	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2.04	3.62	12.89	13.35	0.00	0.45	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	2.95	16.21	13.26	0.00	0.74	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2.56	5.50	22.35	26.75	0.00	2.20	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	6.22	18.67	18.67	0.00	12.44	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	1.07	11.22	13.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	11.59	34.78	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	1.01	14.14	22.22	0.00	2.02	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	1.26	8.01	16.02	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	1.36	2.72	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	1.91	3.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	4.86	2.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	7.55	4.53	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	5.71	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	13.05	32.62	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	9.50	19.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	12.55	37.65	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	40.50	4.96	0.00	0.00	5.39	2.37	1.94	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	55.40	5.23	0.00	0.00	4.70	6.27	3.66	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	29.37	6.67	0.00	0.00	2.00	2.67	2.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	36.31	8.76	0.00	0.00	3.34	1.67	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	55.71	9.32	0.00	0.00	1.52	7.80	2.47	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	90.96	11.17	0.00	0.00	3.19	3.19	0.00	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	35.36	3.40	0.00	0.00	3.40	0.00	0.68	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	1.84	0.00	0.00	1.84	3.68	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	31.81	5.02	0.00	0.00	1.26	1.67	0.42	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.94	2.79	0.00	0.00	1.86	1.63	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	35.13	5.40	0.27	0.00	2.70	0.81	0.81	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	55.08	9.46	0.00	0.00	4.20	0.84	1.26	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	31.27	6.45	0.00	0.00	2.48	0.99	1.49	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.68	2.98	0.00	0.00	1.62	3.79	0.27	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.67	3.17	0.00	0.00	1.81	0.91	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.48	4.74	0.00	0.00	1.31	0.33	0.33	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	32.99	7.11	0.00	0.00	1.09	1.09	1.09	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.16	7.43	0.00	0.00	0.00	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	4.80	0.00	0.00	3.00	0.60	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	40.37	6.89	0.00	0.66	2.63	9.19	2.30	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.51	3.09	0.00	0.00	1.79	0.49	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.45	14.46	0.00	0.00	1.94	1.94	0.35	3.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	0.70	0.00	0.00	0.70	0.70	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.07	4.60	0.00	0.00	0.46	1.38	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.71	4.82	0.00	0.00	1.93	0.96	0.64	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	29.66	6.21	0.00	0.00	2.07	9.66	5.86	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	2.53	0.00	0.00	10.11	7.59	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	42.55	10.47	0.22	0.00	1.11	0.67	0.22	2.90
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	29.64	5.50	0.00	0.00	2.54	1.69	1.27	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.12	4.51	0.00	0.00	1.66	2.14	1.66	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.90	4.72	0.00	0.00	1.29	0.43	0.86	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.66	6.00	0.00	0.00	3.00	1.33	1.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	59.51	6.76	0.00	0.00	2.71	1.80	0.90	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.22	3.57	0.00	0.00	1.98	1.98	1.19	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	5.57	0.00	0.00	3.71	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	4.54	0.00	0.38	1.89	1.51	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	30.63	6.84	0.00	0.00	4.24	2.28	1.96	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	45.76	8.72	0.00	0.44	6.97	3.49	0.87	2.18
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	78.70	9.05	0.00	0.00	8.14	1.81	0.45	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	6.17	0.00	0.00	2.65	2.65	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	16.62	3.32	0.00	0.00	1.33	0.66	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	40.68	7.94	0.00	0.00	2.98	1.49	0.50	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	47.09	4.98	0.00	0.00	4.59	3.83	2.68	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	43.25	9.68	0.00	0.00	1.81	4.23	0.30	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.07	5.75	0.00	0.00	6.19	1.33	0.44	2.65
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.30	4.07	0.00	0.00	1.36	0.68	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	0.00	0.00	0.00	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	8.54	0.00	0.00	1.22	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	57.28	5.04	0.00	0.00	9.76	3.78	2.52	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	41.77	4.54	0.00	0.00	2.72	1.21	1.21	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	44.30	7.12	0.00	0.00	2.37	0.79	0.79	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	48.75	4.53	0.00	0.00	11.34	15.87	11.34	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	0.00	0.00	0.00	0.00	5.06	0.00	5.06
Myoblast, donor1	11241-116D8	23.23	4.47	0.00	0.12	3.11	3.48	2.24	1.61
Myoblast, donor2	11322-117D8	32.41	9.01	0.19	0.19	2.88	3.26	0.96	0.58
Myoblast, donor3	11398-118D3	31.28	9.42	0.67	0.67	1.85	1.35	0.50	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.63	22.04	21.01	11.09	0.00	3.50	1.17	0.15
Natural Killer Cells, donor1	11230-116C6	14.15	18.45	25.83	13.22	0.31	2.46	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	6.63	15.38	14.47	3.92	0.00	1.21	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	10.12	16.93	18.96	8.10	0.00	2.76	0.92	0.74
Neural stem cells, donor1	11275-116H6	15.97	3.27	0.00	0.00	1.81	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	9.63	7.70	0.00	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	3.41	2.28	0.00	0.00	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	1.76	3.08	1.10	0.44	0.00	0.00	0.00	0.44
Neurons, donor3	11655-122E8	2.47	0.82	0.00	0.00	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	3.71	0.93	1.86	4.64	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	2.90	0.00	5.80	0.00	0.00	5.80	0.00
Neutrophils, donor3	11390-118C4	2.44	0.61	1.22	4.28	0.00	0.61	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	83.95	12.94	0.00	0.00	4.27	4.51	2.97	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	43.63	8.79	0.00	0.00	1.30	3.58	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	20.46	4.61	0.20	0.00	2.41	1.40	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	33.31	5.92	0.00	0.00	1.65	3.17	1.38	1.65
Olfactory epithelial cells, donor2	11934-125I8	51.96	8.54	0.00	0.00	6.66	5.79	2.75	1.88
Olfactory epithelial cells, donor3	11935-125I9	48.47	6.24	0.00	0.00	1.82	2.95	2.04	1.36
Olfactory epithelial cells, donor4	11936-126A1	76.16	10.32	0.00	0.00	6.14	3.70	1.17	2.92
Oligodendrocyte - precursors, donor1	11496-119F2	44.53	9.63	0.00	0.00	2.41	3.01	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	21.27	4.25	0.00	0.00	2.98	0.43	0.00	1.70
Osteoblast - differentiated, donor2	11353-117H3	5.72	1.14	0.00	0.00	2.29	0.00	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	13.66	6.21	0.00	0.00	1.86	0.62	0.00	1.24
Osteoblast, donor1	11277-116H8	34.79	4.69	0.00	0.00	3.71	0.59	0.39	0.20
Osteoblast, donor2	11354-117H4	73.74	13.34	0.00	0.00	11.94	4.21	2.11	1.40
Osteoblast, donor3	11426-118G4	45.85	6.22	0.00	0.00	6.40	0.71	0.00	1.42
Pancreatic stromal cells, donor1	11249-116E7	35.97	10.70	0.00	0.00	1.60	2.27	2.70	1.18
Pericytes, donor1	11491-119E6	13.13	3.89	0.00	0.00	1.56	0.22	0.00	0.11
Pericytes, donor2	11571-120E5	14.26	3.40	0.00	0.00	2.04	0.45	0.00	0.45
Pericytes, donor3	11652-122E5	48.22	8.34	0.00	0.00	4.27	3.05	1.42	1.63
Perineurial Cells, donor1	11499-119F5	56.17	7.35	0.00	0.00	7.23	2.71	1.36	0.68
Perineurial Cells, donor2	11579-120F4	13.62	9.11	0.00	0.00	0.55	0.64	0.18	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	9.56	20.72	12.11	13.71	0.32	1.27	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	9.55	9.30	2.45	4.90	0.00	0.73	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	7.64	12.68	6.34	6.60	0.00	0.65	1.16	0.52
Placental Epithelial Cells, donor1	11278-116H9	12.91	6.70	0.00	0.00	0.00	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	29.94	7.76	0.00	0.00	2.22	1.11	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.34	7.07	0.00	0.00	0.39	0.59	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.32	6.33	0.00	0.00	2.53	4.11	2.53	2.22
Preadipocyte - breast, donor1	11467-119B9	28.70	5.25	0.00	0.00	3.38	2.06	0.94	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	48.56	14.49	0.00	0.00	5.22	2.35	1.44	2.48
Preadipocyte - breast, donor2	11328-117E5	25.67	6.98	0.00	0.00	2.70	2.25	2.03	0.45
Preadipocyte - omental, donor1	11468-119C1	24.08	7.25	0.00	0.00	3.30	3.41	1.07	3.20
Preadipocyte - omental, donor2	11329-117E6	39.28	9.17	0.00	0.00	3.93	1.75	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	41.11	8.59	0.00	0.00	5.73	5.73	3.58	3.15
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.00	0.00	0.00	1.97	0.00	0.00	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	35.01	7.37	0.00	0.00	4.30	0.61	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	74.02	19.48	0.00	0.00	4.96	7.97	4.43	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	40.53	7.32	0.00	0.00	2.55	2.38	1.70	0.68
Preadipocyte - visceral, donor1	11280-116I2	67.25	13.13	0.09	0.00	5.50	3.45	2.61	2.98
Preadipocyte - visceral, donor2	11357-117H7	79.15	15.19	0.00	0.00	3.68	10.12	3.22	1.38
Preadipocyte - visceral, donor3	11429-118G7	28.63	5.85	0.00	0.00	3.03	1.78	1.25	2.09
Prostate Epithelial Cells (polarized), donor1	11253-116F2	53.40	16.44	0.15	0.00	1.06	3.77	2.26	0.15
Prostate Epithelial Cells, donor2	11331-117E8	15.98	9.34	0.00	0.00	0.41	1.90	1.22	0.68
Prostate Epithelial Cells, donor3	11404-118D9	13.96	12.92	0.00	0.00	0.24	2.02	0.86	0.18
Prostate Stromal Cells, donor1	11254-116F3	27.45	7.63	0.00	0.00	2.05	2.96	1.71	0.23
Prostate Stromal Cells, donor2	11332-117E9	46.62	8.61	0.00	0.00	2.69	7.53	2.51	1.97
Prostate Stromal Cells, donor3	11405-118E1	17.83	5.53	0.00	0.00	0.42	1.56	1.46	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.87	13.14	0.00	0.00	0.00	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.62	10.54	0.00	0.00	0.14	0.97	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	17.25	10.65	0.00	0.00	0.00	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	9.25	0.00	0.00	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	9.53	12.49	0.11	0.00	0.11	0.74	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	8.17	0.00	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.31	8.36	0.13	0.00	0.81	0.40	0.27	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	55.28	11.10	0.00	0.00	2.22	4.66	2.22	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.30	9.32	0.00	0.00	0.67	0.00	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	23.77	17.61	0.00	0.00	0.88	0.66	0.66	0.88
Renal Mesangial Cells, donor2	11598-120H5	23.20	10.66	0.00	0.00	0.00	1.25	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	17.48	8.60	0.00	0.00	0.00	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.06	13.96	0.27	0.00	0.00	1.34	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	8.01	0.00	0.00	0.84	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.48	11.96	0.00	0.00	0.19	0.96	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.78	12.19	0.52	0.00	0.00	1.04	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.70	10.52	0.00	0.00	0.57	1.71	1.99	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	10.29	0.00	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.80	5.52	0.25	0.00	0.25	2.01	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	71.23	21.25	1.07	1.74	3.88	1.74	1.34	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	12.51	0.00	0.00	0.00	1.79	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	34.67	18.71	0.55	1.65	1.10	6.60	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	51.62	20.88	0.58	1.16	0.00	0.58	0.00	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.48	16.38	0.00	0.00	0.13	0.78	0.13	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.39	13.01	0.00	0.00	0.20	1.29	0.30	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.06	13.16	0.00	0.22	0.56	0.78	0.22	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.88	16.87	0.00	0.00	0.25	0.74	0.50	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.73	13.75	0.00	0.23	0.12	1.86	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.57	16.18	0.00	0.00	0.00	1.85	0.92	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.95	9.86	0.00	0.00	0.14	0.27	0.27	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.57	15.43	0.00	0.15	0.00	1.51	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.23	15.95	0.18	0.18	0.00	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.34	13.92	0.00	0.00	0.14	0.57	0.43	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	16.20	15.35	0.11	0.11	0.32	0.97	0.43	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	18.37	12.61	0.00	0.00	0.00	1.33	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.57	10.90	0.00	0.19	0.76	0.38	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.91	14.53	0.09	0.00	0.19	0.65	0.37	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.42	15.22	0.00	0.19	0.38	1.69	1.13	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.28	13.93	0.00	0.13	0.13	0.40	0.13	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	19.27	15.87	0.00	0.00	0.29	0.58	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.66	14.89	0.00	0.00	0.00	1.53	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.60	15.27	0.00	0.00	0.11	0.32	0.21	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.86	18.50	0.00	0.00	0.28	1.68	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	17.60	14.36	0.00	0.17	0.17	0.51	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	11.85	11.12	0.00	0.00	0.36	0.36	0.00	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.06	16.43	0.12	0.12	0.37	1.35	0.74	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	16.12	13.16	0.00	0.00	0.00	1.75	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.55	9.67	0.00	0.00	0.00	1.42	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.06	12.10	0.00	0.00	0.20	1.59	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	13.80	10.99	0.00	0.00	0.00	0.70	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.75	8.29	0.00	0.21	0.00	0.62	0.21	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	13.94	13.94	0.00	0.00	0.44	0.66	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.05	12.53	0.00	0.00	0.21	1.04	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.04	12.25	0.00	0.13	0.00	0.54	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.24	16.18	0.00	0.00	0.00	0.51	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.58	18.32	0.00	0.00	0.00	1.16	0.39	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.21	15.13	0.00	0.17	0.34	0.34	0.17	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	16.05	14.81	0.00	0.00	0.14	0.27	0.27	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	15.27	11.66	0.00	0.00	0.16	1.31	0.99	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.12	13.80	0.00	0.00	0.00	0.68	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	16.72	14.20	0.15	0.15	0.00	0.44	0.15	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	30.39	16.79	0.00	0.00	0.00	1.33	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.87	17.42	0.00	0.00	0.14	0.83	0.41	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.19	13.81	0.00	0.24	0.00	1.43	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.92	35.47	0.00	0.00	0.81	1.21	1.01	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.65	16.76	0.00	0.47	0.28	0.66	0.38	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.09	26.55	0.00	0.35	0.35	0.35	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.03	14.81	0.30	0.91	0.60	1.21	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.26	18.24	0.00	0.37	0.12	0.73	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	65.79	47.16	0.87	1.89	0.58	2.04	0.58	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.90	23.12	0.61	1.22	0.00	1.83	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	14.77	9.34	0.60	0.30	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	43.88	26.01	0.23	1.36	0.68	1.81	0.90	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	42.24	26.66	0.30	1.50	0.00	2.70	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	24.21	24.32	0.35	1.65	0.59	0.83	0.12	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	36.07	24.76	0.85	0.43	0.64	1.71	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	38.46	23.44	0.00	1.20	0.00	0.60	1.20	0.00
Schwann Cells, donor1	11498-119F4	28.02	10.16	0.00	0.00	1.50	1.50	0.56	1.13
Schwann Cells, donor2	11578-120F3	44.23	6.80	0.00	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	57.18	7.89	0.00	0.00	1.75	5.70	1.75	0.88
Sebocyte, donor1	11220-116B5	46.56	28.48	0.00	0.00	0.00	1.10	0.00	1.10
Sebocyte, donor2	11301-117B5	18.38	6.89	0.00	0.00	1.38	2.30	1.84	0.00
Sebocyte, donor3	11378-118B1	33.80	8.04	0.00	0.21	1.03	1.03	0.41	0.82
Sertoli Cells, donor1	11255-116F4	23.19	9.94	0.00	0.00	0.00	0.00	4.97	3.31
Sertoli Cells, donor2	11333-117F1	16.95	0.00	0.00	0.00	0.00	5.65	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	54.28	14.87	0.00	0.00	3.08	3.08	1.94	1.41
Skeletal Muscle Cells, donor2	11358-117H8	13.73	8.67	0.00	0.00	0.72	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	37.62	13.38	0.00	0.00	0.00	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.36	7.07	0.00	0.00	1.26	0.94	1.10	0.47
Skeletal Muscle Cells, donor5	11455-119A6	21.70	9.96	0.00	0.00	1.34	0.89	0.15	0.74
Skeletal Muscle Cells, donor6	11459-119B1	34.47	12.62	0.00	0.00	2.00	1.69	0.77	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	45.87	14.99	0.00	0.00	2.39	2.02	1.51	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	37.24	10.56	0.00	0.00	0.86	3.00	1.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	60.42	13.99	0.20	0.20	3.67	3.08	2.18	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	37.16	9.35	0.00	0.08	2.53	1.77	1.60	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	2.17	0.00	0.00	1.45	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.92	5.23	0.00	0.00	2.48	0.55	0.28	0.83
Skin - palm, donor1	10286-104F7	56.41	10.74	0.00	0.00	5.37	2.69	2.69	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.18	7.21	0.00	0.00	1.01	1.15	0.58	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	48.26	13.09	0.00	0.00	7.36	8.18	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.01	11.04	0.00	0.00	0.65	1.95	0.39	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	22.10	15.01	0.00	0.00	0.42	1.95	1.53	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	21.52	15.61	0.00	0.00	0.84	1.27	1.27	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	60.26	28.12	0.00	0.00	2.96	3.59	1.69	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	27.51	25.48	0.00	0.00	0.30	1.12	1.65	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	1.85	0.00	0.00	1.23	0.00	0.31	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	35.80	11.78	0.00	0.00	7.34	0.89	0.44	7.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.19	12.34	0.00	0.00	7.05	0.59	0.00	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.88	5.97	0.00	0.00	1.55	0.88	0.66	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	25.20	5.91	0.00	0.00	1.18	0.39	0.39	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	42.49	8.50	0.00	0.00	3.86	1.55	0.77	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	3.00	0.00	0.00	0.00	3.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	33.80	7.45	0.00	0.00	3.73	0.13	0.27	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	81.35	11.30	0.00	0.00	6.87	8.64	6.87	3.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.75	3.71	0.00	0.00	1.28	0.26	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	24.74	5.54	0.00	0.00	3.91	2.60	1.30	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	64.38	12.99	0.00	0.00	7.97	2.66	1.18	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.61	5.41	0.00	0.00	2.42	1.14	0.57	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.14	5.37	0.00	0.00	1.95	0.98	0.33	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	32.88	6.70	0.00	0.00	1.52	5.18	0.30	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.57	10.86	0.00	0.00	1.26	0.76	0.76	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.03	5.72	0.00	0.00	1.43	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	25.51	7.96	0.00	0.00	0.88	1.92	0.59	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.42	6.46	0.00	0.00	1.51	0.86	1.08	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.27	10.29	0.00	0.00	1.99	1.78	1.15	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	28.31	6.34	0.00	0.00	1.24	0.31	0.46	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	1.08	0.00	0.00	5.39	2.16	1.08	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.23	7.47	0.00	0.00	2.09	0.90	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.41	7.17	0.00	0.00	2.05	2.39	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	50.18	9.66	0.00	0.00	2.28	2.43	1.41	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	38.34	6.14	0.00	0.00	4.33	3.02	1.71	2.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	33.45	8.65	0.00	0.00	2.50	2.96	1.14	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.38	3.02	0.00	0.00	5.43	0.60	1.21	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.16	12.72	0.00	0.00	2.12	1.85	1.59	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.38	9.05	0.00	0.00	1.73	1.20	0.93	1.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.05	8.39	0.00	0.00	1.38	3.63	1.25	2.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	20.29	5.58	0.00	0.00	0.76	1.27	0.51	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	42.37	11.16	0.00	0.00	2.11	1.21	0.45	1.81
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	19.50	7.50	0.00	0.00	1.50	0.00	1.50	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	5.17	1.29	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	68.37	13.02	0.00	0.00	9.77	0.47	0.00	4.19
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	45.44	9.59	0.00	0.00	2.52	6.06	3.53	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.94	3.45	0.00	0.00	3.45	0.94	0.63	3.76
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.34	2.65	0.00	0.00	1.47	0.88	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	70.23	11.75	0.00	0.00	4.25	1.75	0.75	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	32.23	2.80	0.00	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	31.52	7.34	0.00	0.00	1.15	1.30	0.29	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	36.20	11.22	0.00	0.25	1.78	1.53	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.15	5.45	0.00	0.00	2.82	0.75	0.00	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	44.16	11.74	0.00	0.00	0.84	2.38	1.96	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	30.75	8.97	0.00	0.00	1.09	1.51	1.09	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	22.86	9.52	0.00	0.00	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	29.85	5.38	0.00	0.00	1.71	0.73	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.68	5.52	0.00	0.00	2.87	1.33	1.10	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.38	7.90	0.00	0.00	0.00	0.59	0.59	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.98	4.66	0.00	0.00	3.11	4.08	1.55	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.89	2.91	0.00	0.00	1.59	3.17	1.59	2.91
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	25.29	4.84	0.00	0.00	1.86	4.84	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.62	4.31	0.00	0.00	2.16	1.80	2.52	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.67	3.41	0.00	0.00	3.12	1.14	1.14	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	65.78	4.73	0.00	0.00	5.51	9.85	4.73	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	24.89	4.83	0.00	0.00	1.02	4.83	2.29	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	26.36	3.99	0.00	0.00	1.60	3.99	2.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	11.29	1.25	0.00	0.00	0.00	2.93	0.84	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	11.00	3.67	0.00	0.00	0.46	2.29	1.38	0.00
Synoviocyte, donor1	11291-117A4	58.41	6.73	0.00	0.00	5.05	5.39	3.20	2.69
Synoviocyte, donor2	11368-117I9	21.46	5.36	0.17	0.17	0.67	2.18	2.18	0.84
Synoviocyte, donor3	11440-118H9	10.05	6.70	0.00	0.00	0.67	1.12	0.22	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	42.17	10.36	0.00	0.00	2.86	1.07	1.43	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	1.98	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	38.90	6.48	0.00	0.00	0.69	0.46	1.16	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	14.34	10.97	0.00	0.00	0.36	0.79	0.72	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	6.57	0.00	0.77	0.39	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	6.87	0.00	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	74.55	22.39	2.09	1.35	2.95	2.46	1.85	0.74
Urethra, donor2	10319-105A4	84.53	16.19	0.00	0.00	7.19	7.19	3.60	1.80
Urothelial Cells, donor1	11520-119H8	20.99	11.95	0.00	0.00	0.27	1.33	1.59	0.00
Urothelial Cells, donor2	11600-120H7	12.82	6.81	0.00	0.00	0.40	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	17.65	7.79	0.00	0.00	0.69	1.60	0.23	0.00
Urothelial cells, donor0	11216-116B1	46.14	24.07	0.00	0.00	0.89	5.57	3.57	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	2.67	11.57	9.79	6.23	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	2.86	11.44	8.58	7.15	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	2.74	9.58	8.21	5.48	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	5.85	12.05	10.33	7.58	0.00	1.72	1.03	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	5.23	13.94	9.30	6.97	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	2.08	13.54	2.08	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	2.75	15.60	8.26	5.51	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	11.87	11.87	4.56	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	7.77	8.51	0.00	0.00	0.37	1.36	0.37	0.00
Wilms' tumor cell line:HFWT	10597-108E3	18.48	7.92	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.61	10.89	0.00	0.00	0.28	1.12	0.56	0.00
achilles tendon, donor2	10292-104G4	14.47	8.27	2.07	6.20	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	42.83	25.50	1.53	1.53	0.76	7.14	3.31	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.36	13.93	0.00	0.00	0.00	1.16	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	3.44	13.41	0.00	0.00	0.00	0.24	0.24	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.80	12.52	0.00	0.00	0.00	1.63	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.22	1.69	6.18	2.25	0.00	0.00	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	10.15	8.46	36.37	15.65	0.21	1.27	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	32.94	20.42	46.28	25.32	0.54	9.26	2.18	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.78	3.53	40.98	22.47	0.44	3.97	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	19.60	10.62	55.54	37.16	0.41	4.90	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	6.60	6.21	17.09	18.64	0.00	1.94	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.07	9.38	15.46	12.70	0.18	1.29	0.55	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	3.90	15.60	11.70	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.89	10.92	21.61	10.46	0.00	1.16	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.03	12.17	0.78	1.29	0.00	0.26	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.38	8.48	7.60	7.60	0.00	2.92	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.44	8.83	6.51	9.30	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.45	19.33	56.34	83.90	0.41	4.52	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.66	11.97	10.44	6.75	0.00	1.84	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.95	8.11	31.15	26.03	0.43	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10.92	14.25	26.99	25.78	0.00	0.91	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	14.44	11.55	33.94	26.48	0.72	2.17	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	10.47	6.24	52.57	27.17	0.22	3.79	0.67	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	102.73	12.67	34.36	39.02	2.67	6.00	1.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	22.30	3.72	13.01	1.86	3.72	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	20.34	4.90	0.38	0.75	0.00	0.75	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	52.34	24.42	54.95	38.82	0.44	2.62	1.31	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	82.48	28.12	20.62	16.87	1.87	13.12	5.62	5.62
adenocarcinoma cell line:IM95m	10796-110I4	24.73	35.56	4.71	4.24	0.47	1.65	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	32.89	16.44	6.05	6.36	1.09	0.62	0.62	1.86
adipose, donor1	10184-103D4	22.87	11.73	0.00	0.00	0.00	7.04	0.00	0.00
adipose, donor2	10185-103D5	19.87	9.33	0.00	0.00	0.00	2.03	1.22	0.41
adipose, donor3	10186-103D6	22.33	6.26	0.00	0.00	0.27	3.27	1.09	0.54
adipose, donor4	10187-103D7	27.74	2.60	0.00	0.00	0.87	6.07	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.84	22.09	0.00	0.00	0.16	0.32	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	29.10	10.91	0.00	0.00	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	11.74	24.81	1.33	4.27	0.00	1.87	2.27	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.22	9.29	0.00	0.00	0.00	0.36	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	80.92	27.36	0.00	0.23	2.78	2.32	0.46	2.09
amniotic membrane cells, donor2	12236-129G4	59.84	16.57	0.00	0.00	3.38	3.72	1.69	0.68
amniotic membrane cells, donor3	12237-129G5	63.63	31.52	0.00	0.00	3.24	1.18	0.00	2.06
amygdala - adult, donor10196	10167-103B5	11.86	5.93	1.19	1.19	1.19	1.19	0.00	1.19
amygdala, adult, donor10252	10151-102I7	16.02	9.94	2.84	3.04	0.41	0.61	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	17.43	3.55	0.32	1.61	1.61	1.29	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	62.01	22.41	0.00	0.00	2.16	2.67	1.66	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.44	7.28	0.00	0.00	0.44	1.76	0.22	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	11.02	16.70	5.01	5.01	0.33	2.34	1.34	0.00
aorta, adult, pool1	10052-101G7	115.52	32.95	1.37	0.78	8.24	2.75	1.96	3.73
appendix, adult	10189-103D9	58.99	23.29	4.66	5.05	5.82	0.39	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	7.91	17.88	0.00	0.00	0.00	1.72	1.03	0.00
artery, adult	10190-103E1	23.10	8.15	0.00	0.00	2.72	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	12.17	15.21	0.00	0.00	0.00	1.30	0.72	0.14
b cell line:RPMI1788	10427-106D4	63.94	43.12	0.15	0.45	1.78	3.87	1.64	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.66	9.71	0.00	0.00	4.44	2.22	2.22	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.12	12.40	0.00	0.00	0.20	0.60	0.30	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	26.95	19.42	0.00	0.00	0.50	3.85	1.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	16.78	1.12	4.47	0.00	2.80	0.56	0.00
bladder, adult, pool1	10011-101C2	49.00	24.99	0.65	0.76	1.30	0.98	0.87	2.82
blood, adult, pool1	10053-101G8	0.00	0.00	6.64	6.64	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	90.77	28.26	0.00	0.00	10.28	4.28	0.00	5.14
bone marrow, adult	10192-103E3	16.20	10.12	4.05	10.80	0.67	4.05	0.00	0.00
brain, adult, donor1	10084-102B3	9.23	7.18	0.00	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	11.47	8.13	1.67	2.00	1.34	0.22	0.89	0.89
brain, fetal, pool1	10085-102B4	2.67	2.67	0.00	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	24.78	25.11	0.00	0.00	0.66	1.32	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	60.16	30.46	0.00	0.00	1.62	1.75	1.25	0.25
breast, adult, donor1	10080-102A8	30.94	10.73	0.00	0.63	0.63	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.40	13.34	0.00	0.00	0.51	1.02	0.76	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	20.72	19.17	0.00	0.00	0.62	0.93	1.24	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.96	18.88	0.00	0.00	0.92	3.22	1.61	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	24.45	10.17	0.00	0.00	0.73	1.21	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	24.45	14.58	0.00	0.00	0.00	1.88	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	43.10	34.67	0.77	0.77	0.44	1.97	0.44	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	50.39	10.77	0.00	0.00	0.00	5.07	2.22	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	17.04	12.24	0.00	0.00	0.80	2.40	1.06	0.53
caudate nucleus - adult, donor10196	10177-103C6	11.51	10.36	0.00	5.76	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	14.89	13.39	0.67	2.34	0.33	0.50	0.50	0.67
caudate nucleus, adult, donor10258	10379-105H1	13.75	4.58	1.53	2.29	0.00	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.82	3.66	0.37	1.10	1.10	0.00	0.73	1.83
cerebellum - adult, donor10196	10173-103C2	8.74	0.00	0.00	0.00	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	9.82	5.55	0.43	1.28	0.64	0.21	0.43	0.21
cerebellum, adult, pool1	10083-102B2	4.14	1.72	0.34	1.38	0.00	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	27.40	1.66	0.83	2.49	0.83	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	17.40	4.29	0.50	1.26	2.27	1.01	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	7.31	2.19	1.46	2.19	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	42.70	14.81	0.00	0.00	2.16	3.59	0.29	1.01
cervical cancer cell line:ME-180	10553-107I4	14.58	14.25	0.00	0.00	0.33	0.66	1.16	0.17
cervix, adult, pool1	10013-101C4	82.63	32.44	1.47	1.05	5.35	3.25	1.26	2.20
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	14.07	11.15	0.00	0.00	0.56	1.67	1.11	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	11.76	0.00	0.00	0.00	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	47.35	24.11	0.00	0.00	1.99	4.47	1.86	0.37
choriocarcinoma cell line:SCH	10785-110H2	40.41	11.71	0.00	0.00	1.48	3.94	0.99	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	31.07	16.13	0.00	0.00	1.19	1.19	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	57.55	23.36	0.00	0.00	2.28	2.85	0.57	2.85
chorionic membrane cells, donor2	12239-129G7	73.28	15.51	0.00	0.20	3.28	3.48	2.19	0.89
chorionic membrane cells, donor3	12240-129G8	74.18	21.43	1.65	1.65	2.20	2.75	1.10	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	3.03	3.03	2.02	0.00	2.02	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.93	12.87	10.95	6.92	0.00	1.92	0.77	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	46.04	14.15	22.81	17.53	0.84	1.69	2.75	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.48	15.15	1.28	2.05	0.26	2.05	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	25.64	15.24	1.21	2.90	0.24	0.48	0.73	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.71	18.32	1.43	1.63	0.20	1.83	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	9.72	10.89	0.00	0.00	0.29	1.47	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	78.19	15.64	22.67	18.50	2.35	3.39	1.56	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.03	11.20	0.00	0.00	0.00	1.60	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	52.92	25.68	0.00	0.00	0.35	2.95	1.74	0.35
colon carcinoma cell line:CACO-2	10513-107D9	61.69	23.80	0.00	0.00	1.10	2.93	1.83	0.55
colon carcinoma cell line:COLO-320	10420-106C6	38.77	44.47	0.00	0.00	0.00	0.76	1.14	0.38
colon, adult, donor1	10082-102B1	38.08	17.85	1.19	2.38	0.00	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	49.94	19.51	10.81	6.93	4.35	1.65	0.35	1.53
colon, fetal, donor1	10070-101I7	31.52	14.83	6.18	4.33	0.62	2.47	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	91.67	32.08	32.08	27.50	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.90	23.80	0.42	0.00	0.85	1.70	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.64	18.11	0.45	1.06	0.15	1.96	0.60	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	15.65	22.84	0.56	1.69	0.14	1.97	0.71	0.14
corpus callosum, adult, pool1	10042-101F6	35.38	24.77	5.31	11.17	3.21	0.33	0.22	1.22
cruciate ligament, donor2	10295-104G7	53.49	13.78	0.00	1.62	0.81	0.81	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	30.50	11.24	0.00	0.80	3.21	0.00	0.00	1.61
diencephalon, adult	10193-103E4	9.84	5.28	1.44	1.20	0.24	0.96	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	22.04	15.15	0.00	0.23	0.23	2.53	1.61	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.62	11.28	0.00	0.00	0.26	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.15	4.33	0.00	0.00	0.00	1.44	0.48	0.00
ductus deferens, adult	10196-103E7	46.84	29.40	0.50	0.00	2.49	1.99	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	14.40	2.88	0.00	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	43.40	19.13	1.47	2.21	0.00	3.68	0.74	0.00
dura mater, adult, donor1	10041-101F5	70.12	21.22	8.26	13.71	13.30	1.32	0.99	3.30
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	11.99	4.89	0.00	0.00	0.44	0.44	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.92	10.75	0.00	0.00	0.00	1.29	0.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	8.63	16.03	0.00	0.00	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	3.94	6.66	0.00	0.00	0.00	0.30	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	4.63	12.04	0.00	0.00	0.00	0.31	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	6.57	9.19	0.00	0.00	0.00	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.47	13.41	0.67	2.68	0.67	0.67	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	15.22	24.10	0.00	0.00	0.18	3.62	1.63	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.51	9.01	0.00	0.00	0.32	1.61	1.61	0.00
epidermoid carcinoma cell line:A431	10426-106D3	14.78	13.45	0.00	0.00	0.00	0.56	0.89	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.04	8.47	0.00	0.00	0.00	0.66	0.33	0.00
epididymis, adult	10197-103E8	74.72	25.95	2.72	3.14	4.60	3.35	1.26	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.60	11.89	0.00	0.00	2.48	2.84	0.89	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	21.63	21.24	0.00	0.00	0.79	1.18	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.47	9.96	0.00	0.00	0.66	1.44	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	26.87	13.19	0.00	0.00	0.39	1.57	1.08	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.65	11.43	0.00	0.00	0.56	2.13	1.12	0.67
esophagus, adult, pool1	10015-101C6	32.49	11.89	0.74	0.96	1.27	1.06	0.42	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	123.48	18.28	0.00	0.00	28.80	2.63	2.25	0.75
eye - muscle inferior rectus, donor1	10272-104E2	19.32	14.49	0.00	0.00	4.83	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	14.73	0.00	0.00	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	40.18	5.95	0.00	0.00	0.00	1.49	1.49	2.98
eye - muscle superior, donor2	10297-104G9	57.32	11.46	0.00	1.15	5.73	1.15	1.15	3.44
eye - vitreous humor, donor1	10268-104D7	5.83	1.46	1.46	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	37.37	9.66	0.76	0.25	2.80	1.27	1.27	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	45.26	10.77	0.00	0.00	1.15	3.46	1.15	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	23.50	12.35	0.00	0.00	0.00	2.61	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	11.63	9.48	1.22	2.44	0.84	0.28	0.09	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	12.01	6.61	0.00	0.00	0.30	1.50	0.60	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	30.27	37.58	0.00	0.00	0.55	1.74	0.37	0.09
gall bladder, adult	10198-103E9	36.70	25.11	2.17	1.93	1.45	0.72	0.48	1.21
gamma delta positive T cells, donor1	11937-126A2	3.76	18.25	34.36	4.29	0.00	1.61	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	5.23	10.08	30.63	10.83	0.00	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	4.65	4.44	0.00	0.00	0.00	1.06	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	12.77	11.80	0.00	0.00	0.00	1.35	0.39	0.19
gastric cancer cell line:AZ521	10549-107H9	6.89	20.82	0.00	0.00	0.16	0.66	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	1.83	10.98	0.00	0.00	0.00	1.83	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	20.79	14.85	0.00	0.00	0.46	2.28	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	6.08	4.59	0.00	0.00	0.23	0.92	0.46	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	8.82	6.30	1.96	0.84	0.14	0.42	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.72	9.23	0.00	0.00	0.00	1.50	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.19	11.93	0.00	0.00	0.11	0.42	0.42	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.27	10.81	0.00	0.00	0.00	1.12	0.56	0.42
glioblastoma cell line:T98G	10485-107A8	43.93	19.98	0.00	0.11	0.44	4.30	2.10	0.55
glioma cell line:GI-1	10413-106B8	52.43	19.62	0.00	0.00	0.88	0.29	1.17	2.34
globus pallidus - adult, donor10196	10175-103C4	22.60	6.56	2.19	2.92	0.73	2.19	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	37.59	27.58	4.88	7.57	0.98	1.46	1.46	0.24
globus pallidus, adult, donor10258	10367-105F7	9.58	16.43	1.37	6.85	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.45	4.26	0.00	1.07	0.00	0.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	78.31	14.68	17.13	0.00	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	21.86	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	63.68	11.20	0.00	0.00	4.80	2.56	1.28	1.92
hIPS +CCl2, biol_rep1	14383-156B9	16.99	4.59	0.00	0.00	0.00	2.75	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.92	3.66	0.00	0.46	0.91	1.37	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	16.10	3.22	0.00	0.00	0.00	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	8.62	2.87	0.00	0.00	0.00	2.87	1.44	0.00
hIPS, biol_rep2	14381-156B7	5.49	3.43	0.00	0.00	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	7.72	2.21	3.31	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	1.72	3.74	0.00	0.00	0.00	0.57	0.57	0.29
heart - mitral valve, adult	10205-103F7	97.76	20.93	0.00	1.20	12.56	2.99	0.90	2.39
heart - pulmonic valve, adult	10206-103F8	53.08	23.27	1.05	1.05	4.45	1.83	1.57	2.09
heart - tricuspid valve, adult	10207-103F9	24.98	14.15	0.83	0.83	1.67	1.67	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	36.73	14.49	0.00	0.20	0.82	4.69	1.22	0.41
heart, adult, diseased, donor1	10051-101G6	25.55	11.50	0.43	0.85	1.28	1.70	0.43	0.85
heart, adult, pool1	10016-101C7	11.96	7.36	0.23	0.23	0.23	0.23	0.00	1.61
heart, fetal, pool1	10046-101G1	48.57	25.26	0.31	0.72	2.26	1.33	0.51	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	98.11	17.89	0.00	0.00	5.55	5.24	4.63	2.16
hepatoblastoma cell line:HuH-6	10633-108I3	108.22	40.43	0.00	0.00	1.19	2.38	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	134.58	29.61	0.11	0.11	4.75	6.19	3.43	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	135.09	32.53	0.00	0.12	4.13	5.46	3.76	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	154.41	34.66	0.10	0.00	4.04	5.56	3.44	1.01
hepatoma cell line:Li-7	10484-107A7	7.23	4.67	0.00	0.00	0.00	0.11	0.44	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	15.08	12.06	1.81	1.81	0.10	1.01	0.50	0.30
hippocampus - adult, donor10196	10169-103B7	6.62	3.79	1.89	0.95	0.00	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	21.02	12.45	1.22	4.90	0.61	0.20	0.00	0.82
hippocampus, adult, donor10258	10374-105G5	3.49	2.49	1.99	1.00	0.00	1.00	0.00	1.99
hippocampus, newborn, donor10223	10363-105F3	7.05	2.11	1.76	0.35	0.70	0.35	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	36.01	3.05	0.00	0.00	2.44	14.04	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	30.04	5.69	0.00	0.00	0.39	2.95	1.57	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.18	3.05	0.00	0.00	1.02	4.57	2.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.71	7.33	0.00	0.00	0.00	2.82	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	13.94	8.26	0.00	0.00	0.26	1.55	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	10.63	9.87	0.00	0.00	0.38	2.28	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.56	5.55	0.00	0.00	0.88	2.34	1.17	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	17.02	8.62	0.00	0.00	0.43	0.65	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.44	6.67	0.00	0.00	0.42	2.09	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	22.26	4.74	0.00	0.00	0.47	1.42	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	32.14	7.88	0.00	0.00	0.64	1.13	0.64	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	4.04	0.67	0.00	1.35	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	24.41	4.07	0.00	0.00	0.78	1.10	0.78	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	22.60	9.83	0.00	0.00	0.49	1.47	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.93	3.49	0.00	0.00	0.87	7.85	6.11	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.30	12.79	0.00	0.00	0.19	1.53	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	22.68	12.65	0.00	0.00	0.87	0.87	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.49	6.00	0.00	0.00	0.00	3.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.40	10.36	0.00	0.00	0.19	0.94	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.46	10.91	0.00	0.00	0.00	1.36	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.05	9.71	0.00	0.00	0.31	3.76	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	30.37	5.23	0.16	0.00	1.80	1.47	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.64	7.84	0.00	0.00	0.29	1.45	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.31	5.68	0.00	0.00	1.49	2.09	1.49	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	22.35	5.17	0.00	0.00	0.55	0.92	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.97	5.14	0.00	0.00	1.14	1.14	1.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	34.30	6.94	0.00	0.00	1.63	6.12	2.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	31.34	9.15	0.00	0.00	1.06	2.46	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	21.22	8.24	0.00	0.00	0.63	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.14	9.38	0.00	0.00	0.00	2.72	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	8.27	0.00	0.00	1.03	2.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	30.55	11.29	0.00	0.00	2.66	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.42	8.21	0.00	0.00	0.51	1.54	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	47.55	6.90	0.00	0.00	1.79	2.30	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	4.54	0.00	0.00	0.76	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	41.67	5.71	0.00	0.00	1.01	5.04	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.39	6.04	0.00	0.00	0.00	0.97	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	3.12	0.00	0.00	0.45	3.57	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.88	4.88	0.00	0.00	1.95	4.39	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.45	7.95	0.00	0.00	0.61	1.53	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	65.06	3.25	0.00	0.00	0.00	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	28.79	10.26	0.00	0.00	0.00	6.62	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	16.97	8.76	0.00	0.00	1.64	1.09	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	25.69	6.88	0.00	0.00	0.72	2.17	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.86	8.90	0.00	0.00	0.00	0.71	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	3.58	0.00	0.00	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	24.24	8.67	0.00	0.00	0.41	0.68	0.54	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.97	4.04	0.00	0.00	0.27	1.89	0.54	0.00
immature langerhans cells, donor1	11904-125F5	32.45	14.04	0.48	1.70	1.94	0.97	1.45	3.63
immature langerhans cells, donor2	11905-125F6	15.05	7.13	0.00	0.79	1.58	0.00	3.17	0.79
insula, adult, pool1	10039-101F3	11.83	9.94	2.18	3.60	0.19	0.28	0.19	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	3.90	9.75	0.00	0.00	0.00	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	44.26	21.63	2.00	2.00	3.10	1.00	0.30	0.10
kidney, fetal, pool1	10045-101F9	47.89	31.12	0.28	0.50	1.91	1.20	0.35	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.66	17.33	0.00	0.00	0.71	0.71	0.99	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.44	7.47	0.00	0.00	0.41	1.24	0.83	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	17.62	10.64	0.00	0.00	0.55	0.37	0.55	0.55
left atrium, adult, donor1	10079-102A7	24.52	8.72	1.09	1.63	0.00	1.63	0.54	1.09
left ventricle, adult, donor1	10078-102A6	14.66	7.58	0.51	0.51	0.51	0.51	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	35.57	12.59	0.00	0.00	1.09	0.55	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	9.70	3.23	0.00	0.00	1.08	1.08	0.00	0.72
leiomyoma cell line:15242A	10570-108B3	7.61	4.35	0.00	0.00	0.54	2.17	0.54	1.09
leiomyoma cell line:15425	10571-108B4	12.63	6.07	0.00	0.00	0.97	1.70	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00	0.00	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	5.23	0.00	0.00	0.00	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.02	7.56	2.95	2.36	0.24	1.89	0.94	0.59
liposarcoma cell line:KMLS-1	10782-110G8	56.08	12.50	0.16	0.00	3.44	2.97	1.09	0.78
liposarcoma cell line:SW 872	10726-110A6	28.63	18.40	0.00	0.00	0.85	0.97	0.97	0.73
liver, adult, pool1	10018-101C9	23.82	11.02	1.13	1.30	1.46	0.49	0.49	0.16
liver, fetal, pool1	10086-102B5	15.99	9.41	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	19.25	7.44	2.48	2.19	0.44	0.44	0.15	0.58
locus coeruleus, adult, donor10252	10165-103B3	16.43	10.70	1.29	2.77	0.74	1.66	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	8.18	3.95	0.56	3.10	0.85	1.13	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	18.09	6.73	3.79	4.63	1.26	0.42	0.84	2.10
lung adenocarcinoma cell line:A549	10499-107C4	24.36	29.89	0.00	0.00	0.55	0.42	0.55	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	42.74	34.47	0.00	0.00	0.00	0.69	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	137.22	84.36	0.00	0.66	1.98	3.69	1.58	1.19
lung, adult, pool1	10019-101D1	29.18	24.69	2.72	4.84	2.01	0.83	0.35	0.24
lung, fetal, donor1	10068-101I5	41.67	39.39	1.14	1.43	2.57	0.29	0.57	1.14
lung, right lower lobe, adult, donor1	10075-102A3	30.70	17.41	5.04	5.96	0.92	1.83	0.92	0.92
lymph node, adult, donor1	10077-102A5	31.24	10.89	5.21	0.95	4.73	1.89	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	61.15	40.55	0.00	0.00	0.44	7.01	2.41	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.28	17.96	0.00	0.30	0.00	1.81	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	24.64	10.19	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	43.07	12.88	0.00	0.44	6.22	1.33	0.44	4.44
mature adipocyte, donor2	12232-129F9	45.24	12.87	0.21	0.42	7.26	1.04	0.21	4.36
mature adipocyte, donor3	12233-129G1	43.86	10.19	0.24	0.24	8.77	1.42	0.24	6.87
mature adipocyte, donor4	12234-129G2	34.74	6.84	0.00	0.00	5.00	1.58	0.53	4.74
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.97	47.89	0.00	0.00	0.00	0.71	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	10.15	1.13	0.00	0.00	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	16.55	11.77	1.10	2.57	0.37	0.37	0.18	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	0.95	3.49	0.32	0.64	0.00	2.54	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	13.65	2.13	1.71	1.71	1.28	0.85	0.85	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	10.46	6.41	0.00	1.35	0.00	1.01	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	23.34	13.79	1.70	3.61	0.21	0.85	0.21	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	0.00	1.93	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.28	3.95	0.36	1.08	0.72	1.08	0.36	1.79
medulla oblongata - adult, donor10196	10174-103C3	46.73	5.84	3.24	3.24	4.54	3.89	0.00	2.60
medulla oblongata, adult, donor10252	10155-103A2	34.21	15.48	4.18	5.42	1.24	1.70	0.46	1.08
medulla oblongata, adult, pool1	10038-101F2	22.61	14.69	3.92	7.51	2.12	0.24	0.08	1.63
medulla oblongata, newborn, donor10223	10361-105F1	15.97	6.60	1.04	1.39	2.08	2.08	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	26.79	8.41	0.00	0.00	1.11	0.89	1.11	0.22
medulloblastoma cell line:ONS-76	10759-110E3	29.47	16.02	0.00	0.00	0.37	0.98	0.73	0.86
melanoma cell line:COLO 679	10514-107E1	20.99	23.72	0.57	0.14	0.14	1.01	0.72	1.15
melanoma cell line:G-361	10465-106H6	37.73	31.76	0.00	0.00	1.63	5.43	3.26	0.81
meningioma cell line:HKBMM	10691-109F7	35.64	13.21	0.18	0.00	0.36	1.99	1.45	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	120.72	16.74	0.00	0.00	2.64	2.64	4.41	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	34.74	12.96	0.00	0.00	0.00	2.07	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	56.92	11.20	0.00	0.00	6.29	1.53	0.77	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.72	6.91	0.00	0.00	3.27	0.91	0.36	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.15	5.80	0.00	0.00	4.14	0.83	0.83	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.72	8.99	0.00	0.00	1.26	0.98	0.28	1.40
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.33	4.24	0.00	0.00	0.39	0.96	0.00	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	3.47	0.00	0.00	2.08	2.08	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.16	9.27	0.00	0.00	1.72	0.51	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.18	6.10	0.00	0.00	1.84	0.12	0.23	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	40.45	9.28	0.00	0.00	4.24	1.19	0.80	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	40.38	12.02	0.00	0.00	3.24	1.35	1.08	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	50.08	12.23	0.00	0.00	3.13	1.99	0.85	1.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	35.24	10.54	0.00	0.00	1.98	1.98	2.63	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	44.28	12.59	0.00	0.00	2.63	2.08	0.69	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	48.17	12.22	0.00	0.00	2.79	5.59	2.09	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.89	8.37	0.00	0.00	1.43	0.20	0.41	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	42.06	6.83	0.00	0.00	2.16	3.95	1.44	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.93	9.31	0.00	0.00	1.45	0.83	0.21	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.03	3.65	0.00	0.00	1.14	0.91	1.14	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.05	7.97	0.00	0.00	3.36	1.26	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	43.93	8.67	0.00	0.00	3.29	1.05	0.15	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.70	10.77	0.00	0.00	1.05	0.79	0.70	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.82	9.20	0.00	0.00	3.68	1.47	1.10	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	39.78	6.87	0.00	0.00	4.58	2.00	1.72	2.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	30.73	10.53	0.42	0.00	0.42	5.05	2.95	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.57	6.85	0.46	0.00	2.74	1.37	0.91	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.30	7.67	0.00	0.00	2.30	2.81	1.28	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.89	3.14	0.00	0.00	2.88	2.36	2.88	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.05	6.78	0.00	0.00	4.01	1.85	1.23	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.13	4.00	0.00	0.00	2.59	3.29	0.71	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.14	6.77	0.00	0.00	3.72	4.40	1.02	3.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	28.69	5.11	0.00	0.00	3.93	3.54	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.10	6.49	0.00	0.00	4.17	3.71	1.85	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.88	6.06	0.00	0.00	4.61	2.02	1.73	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	32.80	6.92	0.00	0.00	2.90	3.12	0.89	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	37.25	5.29	0.00	0.00	3.85	2.64	1.20	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.07	13.20	0.00	0.73	4.40	1.47	0.73	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.50	5.37	0.00	0.00	2.69	3.02	2.01	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	33.16	8.19	0.00	0.00	2.05	2.05	2.46	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.51	6.87	0.00	0.00	3.87	1.72	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	13.67	0.00	0.00	2.73	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00	5.16	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.43	4.22	0.00	0.00	2.92	2.92	1.62	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	7.27	0.00	0.00	4.36	2.91	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	29.85	5.33	0.00	0.00	3.73	1.60	1.60	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	36.80	3.27	0.00	0.00	1.64	2.45	4.91	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	36.93	4.28	0.00	0.00	4.28	4.66	2.72	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	6.30	0.00	0.00	0.00	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	33.78	5.96	0.00	0.00	2.98	0.99	0.00	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	14.30	0.00	0.00	4.77	19.07	23.84	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.03	5.93	0.00	0.00	4.15	5.34	2.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	43.86	7.31	0.00	0.00	3.66	4.87	1.22	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	36.10	5.70	0.00	0.00	5.07	8.87	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.97	1.38	0.00	0.00	2.07	2.07	0.34	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	6.45	0.00	0.00	2.15	4.30	10.75	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	3.99	0.00	0.00	15.97	0.00	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	3.44	0.00	0.00	3.44	17.22	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.30	3.26	0.00	0.00	1.63	3.67	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	1.59	0.00	0.00	1.59	5.56	1.59	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	1.77	0.00	0.00	2.36	6.48	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.18	2.81	0.00	0.00	1.87	5.30	2.18	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	36.09	1.34	0.00	0.00	1.34	9.36	5.35	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	4.73	0.00	0.00	3.55	3.55	5.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	5.14	0.00	0.00	0.00	12.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.09	5.51	0.00	0.00	2.07	3.44	2.75	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	4.45	0.00	0.00	0.00	0.99	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	4.49	0.00	0.00	2.24	6.73	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.18	5.72	0.00	0.00	0.00	1.91	2.54	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.64	2.01	0.00	0.00	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	0.00	0.00	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	5.07	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	2.43	0.00	0.00	1.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	4.52	0.00	0.00	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	3.29	0.00	0.00	0.00	2.47	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.10	2.78	0.00	0.00	0.20	0.40	0.40	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.22	2.27	0.00	0.00	0.65	2.60	1.30	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	8.15	0.00	0.00	2.04	2.04	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	14.70	0.00	0.00	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	55.99	37.33	0.00	0.00	0.47	3.31	1.89	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	58.85	20.85	0.00	0.00	2.32	2.78	4.40	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	4.27	0.00	0.00	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.47	5.03	0.00	0.00	0.31	2.47	0.62	0.41
mesothelioma cell line:Mero-25	10850-111F4	4.77	2.04	0.00	0.00	0.00	0.68	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	35.69	15.40	0.00	0.00	1.22	2.69	1.22	1.22
mesothelioma cell line:Mero-48a	10852-111F6	25.91	11.74	0.22	1.33	0.66	1.33	1.55	1.99
mesothelioma cell line:Mero-82	10853-111F7	11.30	4.20	0.00	0.00	1.05	2.10	0.79	0.79
mesothelioma cell line:Mero-83	10854-111F8	34.55	5.79	0.17	0.17	2.21	1.87	1.02	1.19
mesothelioma cell line:Mero-84	10855-111F9	13.40	3.79	0.00	0.00	0.25	1.52	1.52	0.00
mesothelioma cell line:Mero-95	10856-111G1	13.25	7.87	0.00	0.00	0.41	1.24	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	20.37	5.30	0.00	0.00	0.83	2.32	0.83	0.66
mesothelioma cell line:NCI-H226	10846-111E9	17.38	5.97	0.00	0.00	1.09	1.09	0.90	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	51.76	14.01	0.00	0.00	2.73	4.27	1.54	0.51
mesothelioma cell line:NCI-H28	10845-111E8	2.04	2.80	0.00	0.00	0.00	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	17.61	4.24	0.00	0.00	0.33	1.63	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	14.36	2.44	0.00	0.00	0.27	0.81	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	11.52	15.55	1.15	0.96	0.19	0.96	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	7.82	11.72	0.37	1.71	0.12	0.49	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	3.77	13.10	1.44	3.23	0.18	0.54	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	14.37	5.88	0.00	0.00	0.00	2.29	1.63	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	21.41	4.24	0.00	0.00	1.27	1.91	1.27	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.26	25.11	0.23	0.00	0.92	2.07	0.92	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2.47	7.04	0.57	1.33	0.00	0.57	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	14.23	11.46	20.33	18.48	0.00	2.59	1.29	0.18
myeloma cell line:PCM6	10474-106I6	37.16	39.93	0.59	1.98	0.40	7.31	2.97	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	54.79	14.20	0.00	0.00	2.03	4.06	1.52	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	71.39	21.97	0.00	0.00	3.53	3.73	2.55	4.71
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.58	11.92	0.00	0.00	0.11	0.67	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.37	10.08	0.00	0.00	0.37	1.40	0.66	0.07
nasal epithelial cells, donor2	12227-129F4	17.11	9.38	0.00	0.55	1.10	2.21	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	49.92	23.70	0.00	0.00	0.46	1.61	0.69	0.69
neuroblastoma cell line:NB-1	10539-107G8	5.61	7.86	0.00	0.00	0.19	0.56	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	14.34	7.80	0.00	0.00	0.84	1.48	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	19.19	12.11	0.00	0.00	0.75	1.12	0.19	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	37.72	11.39	0.00	0.00	0.24	2.85	0.71	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	10.45	2.53	0.00	0.00	0.32	1.58	0.48	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	21.74	9.06	0.00	0.00	0.60	1.61	2.01	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.25	5.72	0.00	0.00	0.00	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	58.02	10.91	0.00	0.00	8.52	2.93	1.60	3.46
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	28.41	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	52.60	55.47	0.17	0.51	0.17	2.20	2.37	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	2.40	4.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.38	5.77	0.00	0.00	3.21	4.17	1.92	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.33	6.57	0.00	0.00	1.05	2.10	1.58	0.53
nucleus accumbens, adult, pool1	10037-101F1	13.22	13.50	1.41	1.97	1.12	0.37	0.19	0.94
occipital cortex - adult, donor10196	10172-103C1	8.24	10.30	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	21.74	15.57	3.22	3.49	0.81	1.34	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	14.19	2.91	0.36	1.82	1.09	1.46	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	5.51	5.25	0.79	0.79	0.26	0.52	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	3.86	1.29	0.43	0.43	0.00	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	6.62	7.17	1.10	1.97	0.39	0.16	0.08	0.63
olfactory region, adult	10195-103E6	9.55	6.50	0.57	2.29	0.57	0.19	0.19	0.00
optic nerve, donor1	10277-104E7	28.01	14.01	2.00	0.00	6.00	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	30.64	30.98	0.00	0.00	0.23	2.16	1.25	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.30	20.06	0.00	0.00	0.00	1.37	0.41	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	4.74	3.05	0.00	0.00	0.00	0.17	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	2.19	6.24	0.00	0.12	0.12	0.46	0.35	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	42.63	15.58	0.00	0.00	2.35	2.65	1.18	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	74.75	34.57	0.00	0.00	0.00	1.87	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	25.87	7.21	0.00	0.00	0.00	1.06	0.64	0.00
ovary, adult, pool1	10020-101D2	65.78	25.68	0.70	0.52	4.28	1.14	0.44	2.53
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	48.40	18.70	0.00	0.00	4.40	4.40	2.57	0.73
pancreas, adult, donor1	10049-101G4	30.10	17.87	0.00	0.00	1.88	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.90	6.99	0.00	0.00	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	28.28	10.22	0.00	0.17	0.34	1.36	2.04	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.30	26.49	1.66	2.15	0.83	1.32	0.83	0.33
paracentral gyrus, adult, pool1	10035-101E8	8.05	7.96	1.37	2.47	0.18	0.09	0.09	0.37
parietal cortex, adult, donor10258	10373-105G4	7.34	2.20	0.00	0.00	0.00	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	8.46	0.94	0.94	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	11.40	6.56	1.71	3.14	0.29	0.00	0.29	1.14
parietal lobe, adult, pool1	10034-101E7	12.69	10.31	0.88	1.85	0.53	0.26	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	2.91	3.88	0.97	0.97	0.00	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	12.71	2.24	0.37	1.87	0.75	1.12	0.00	1.50
parotid gland, adult	10199-103F1	90.03	33.30	0.00	0.00	6.78	4.93	5.55	1.85
penis, adult	10200-103F2	49.41	17.72	1.07	0.54	3.22	2.15	0.54	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.07	4.46	0.00	0.00	0.00	0.56	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.55	12.38	0.00	0.00	0.73	0.87	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	59.34	31.61	0.00	0.00	1.29	5.81	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	29.61	34.94	1.18	2.37	0.00	1.78	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	15.05	16.30	1.88	0.63	1.25	0.63	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	112.31	57.67	0.00	1.01	2.02	8.09	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	122.48	101.11	1.56	3.13	1.04	4.17	1.56	3.65
pituitary gland, adult, donor10258	10378-105G9	87.68	54.48	0.00	0.85	1.70	7.66	4.26	4.26
placenta, adult, pool1	10021-101D3	229.95	51.49	3.01	2.47	10.97	5.91	1.83	1.83
plasma cell leukemia cell line:ARH-77	10840-111E3	38.14	29.80	1.06	0.53	0.26	2.65	1.85	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	66.30	21.32	0.00	0.31	1.40	3.89	2.33	0.31
pons, adult, pool1	10033-101E6	15.49	8.86	3.01	3.10	0.86	0.52	0.17	0.95
postcentral gyrus, adult, pool1	10032-101E5	9.24	7.15	1.05	1.83	0.44	0.09	0.00	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	54.38	8.37	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	16.52	16.52	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.05	13.11	0.00	0.00	0.15	1.75	1.02	0.15
prostate cancer cell line:PC-3	10439-106E7	24.87	27.59	0.00	0.00	0.18	2.90	0.91	0.36
prostate, adult, pool1	10022-101D4	37.64	24.40	1.27	1.63	1.72	1.00	0.45	1.27
putamen, adult, donor10196	10176-103C5	11.80	10.86	2.12	1.42	0.00	0.94	0.00	0.71
putamen, adult, donor10252	10152-102I8	11.76	5.88	3.92	1.96	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	5.46	0.00	1.09	0.00	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	6.04	7.49	0.48	1.45	0.24	1.21	0.48	0.24
putamen, newborn, donor10223	10365-105F5	18.74	6.00	3.00	6.75	0.00	1.50	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	35.49	29.38	0.29	0.00	0.87	2.33	0.29	0.87
rectum, fetal, donor1	10067-101I4	59.81	19.47	4.17	0.00	2.78	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	46.22	34.13	0.21	0.00	0.64	2.97	1.70	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1.24	5.38	0.00	0.00	0.00	0.83	0.83	0.00
retina, adult, pool1	10030-101E3	83.99	31.41	2.09	3.38	7.95	0.60	0.30	2.19
retinoblastoma cell line:Y79	10475-106I7	4.68	9.61	0.00	0.00	0.00	0.52	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.31	12.42	0.00	0.00	2.58	1.35	0.61	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	49.77	28.40	0.00	0.00	0.84	1.69	0.84	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	73.51	12.88	0.00	0.00	4.55	1.52	1.52	3.79
salivary acinar cells, donor1	11771-123I7	21.20	9.55	0.00	0.00	0.65	1.78	0.65	0.32
salivary acinar cells, donor2	11772-123I8	22.44	8.81	0.00	0.00	0.83	0.96	1.10	0.96
salivary acinar cells, donor3	11773-123I9	48.33	11.25	0.00	0.00	1.99	1.32	1.99	0.66
salivary gland, adult, pool1	10093-102C3	45.18	37.18	2.29	1.72	9.72	2.86	1.14	5.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.43	11.04	0.00	0.00	0.67	1.52	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	19.40	11.52	0.12	0.24	0.35	1.65	0.71	0.59
seminal vesicle, adult	10201-103F3	58.20	35.98	0.00	2.12	2.65	5.29	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.11	10.93	0.00	0.00	0.49	1.70	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.03	5.03	0.00	0.00	0.00	0.50	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	6.02	0.00	0.00	0.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	66.76	31.70	0.00	0.00	0.67	5.37	2.01	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	5.64	8.07	0.33	0.33	0.11	0.55	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	1.81	7.48	0.00	0.00	0.13	0.26	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	6.38	7.09	0.71	0.00	0.71	0.71	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	11.99	6.12	0.12	0.72	0.96	0.48	0.12	0.60
skeletal muscle, fetal, donor1	10066-101I3	26.13	15.08	0.00	1.01	2.01	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	58.70	20.20	0.63	0.00	4.42	1.26	1.89	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	8.00	12.67	0.00	0.00	0.00	0.67	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.20	9.77	0.00	0.00	0.00	0.63	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	2.12	8.67	0.00	0.00	0.00	0.39	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	3.30	6.59	0.00	0.00	0.00	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	10.94	13.67	0.00	0.00	0.00	0.32	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	39.66	40.75	0.00	0.00	0.65	2.40	1.53	1.53
small intestine, adult, pool1	10024-101D6	58.53	24.49	33.44	16.01	2.39	2.15	0.96	1.43
small intestine, fetal, donor1	10064-101I1	31.69	16.46	1.23	1.23	1.47	2.46	1.23	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.87	33.34	0.00	0.00	0.00	4.10	1.54	1.03
smooth muscle, adult, pool1	10048-101G3	38.51	19.38	0.26	0.26	2.07	2.07	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	61.91	63.25	0.00	0.00	0.27	2.68	1.61	3.22
spinal cord - adult, donor10196	10181-103D1	20.88	10.78	1.15	2.52	1.15	0.69	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	20.11	12.22	8.28	9.07	0.79	0.79	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	8.99	4.84	4.84	4.15	0.69	3.46	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	50.62	9.15	2.44	3.05	2.44	1.83	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	16.99	6.89	2.76	6.43	1.38	2.30	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	71.84	17.03	0.00	0.00	10.01	4.33	1.79	3.73
spleen, adult, pool1	10025-101D7	27.53	17.18	4.19	3.30	1.10	1.43	0.22	0.77
spleen, fetal, pool1	10044-101F8	32.10	25.11	3.50	3.73	0.79	0.56	0.24	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.08	13.66	0.10	0.21	0.31	1.55	1.55	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	9.68	14.05	0.00	0.00	0.00	1.52	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	50.67	24.11	0.00	0.70	1.05	4.89	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.80	13.68	0.00	0.00	0.39	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	3.38	4.28	0.00	0.00	0.11	0.23	0.34	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.35	5.51	0.00	0.00	0.00	2.12	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.88	12.69	0.00	0.00	0.00	1.27	0.85	0.42
stomach, fetal, donor1	10062-101H8	112.14	19.22	1.07	0.00	2.14	8.54	1.07	4.27
submaxillary gland, adult	10202-103F4	78.62	33.61	1.14	1.14	6.27	2.85	0.57	2.85
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	54.27	0.00	325.64	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	35.73	21.39	4.36	6.85	1.04	1.87	1.25	1.04
substantia nigra, adult, donor10258	10371-105G2	4.14	0.52	0.52	1.03	1.03	1.55	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	30.38	8.48	0.71	1.41	0.71	4.24	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.86	21.09	0.00	0.00	0.23	1.83	0.69	0.69
temporal lobe, adult, pool1	10031-101E4	10.77	9.66	1.86	2.29	0.25	0.17	0.00	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	2.14	1.42	0.71	1.42	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.11	1.76	1.32	1.32	0.44	0.88	0.00	0.00
tenocyte, donor1	11763-123H8	37.70	10.12	0.00	0.00	1.40	3.14	4.19	1.40
tenocyte, donor2	11765-123I1	17.55	6.10	0.00	0.00	0.38	3.43	2.67	0.76
tenocyte, donor3	11768-123I4	20.76	4.45	0.00	0.00	1.85	2.97	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	18.87	12.24	0.00	0.00	0.51	1.87	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	21.58	7.09	0.00	0.00	0.92	1.54	1.23	0.31
teratocarcinoma cell line:PA-1	10807-111A6	37.19	6.35	0.00	0.00	1.24	2.79	1.24	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	11.30	8.12	0.00	0.00	0.38	1.27	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.70	6.43	0.00	0.00	0.00	0.76	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	5.23	4.69	0.00	0.00	0.22	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	3.91	4.89	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	41.12	19.54	1.07	1.72	2.04	1.18	0.54	2.47
testis, adult, pool2	10096-102C6	24.81	15.34	0.90	0.90	1.80	3.16	0.90	1.35
thalamus - adult, donor10196	10168-103B6	20.98	9.94	3.31	5.52	0.00	2.21	2.21	1.10
thalamus, adult, donor10252	10154-103A1	28.91	17.82	2.81	7.19	0.31	1.09	0.47	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	4.62	1.54	3.08	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.27	3.13	1.48	2.80	0.00	2.14	0.82	0.49
thalamus, newborn, donor10223	10366-105F6	13.23	2.88	0.58	0.00	2.30	2.30	0.00	1.15
throat, adult	10209-103G2	48.44	14.73	1.25	3.50	4.24	2.00	0.50	1.00
throat, fetal, donor1	10061-101H7	64.90	24.68	0.61	0.00	5.79	5.18	1.83	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	9.94	8.94	0.00	0.00	0.00	0.79	0.40	0.00
thymus, adult, pool1	10027-101D9	13.12	17.20	1.69	3.98	0.40	0.60	0.40	0.40
thymus, fetal, pool1	10043-101F7	23.07	24.63	1.04	1.87	0.52	0.21	0.10	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	55.84	16.09	0.00	0.00	0.66	3.06	1.33	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	36.60	9.64	0.00	0.00	1.12	3.07	1.26	1.82
thyroid, adult, pool1	10028-101E1	101.24	46.28	0.47	0.75	9.42	3.55	1.49	2.43
thyroid, fetal, donor1	10060-101H6	178.76	34.28	0.00	0.26	49.83	10.28	2.64	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	98.55	27.72	0.00	3.08	9.24	3.08	0.00	9.24
tongue, adult	10203-103F5	23.72	11.40	0.23	0.47	1.16	1.40	0.23	2.56
tongue, fetal, donor1	10059-101H5	39.80	14.19	0.39	0.00	2.76	1.97	1.58	0.79
tonsil, adult, pool1	10047-101G2	54.40	26.85	3.41	4.21	4.31	0.60	0.50	1.90
trachea, adult, pool1	10029-101E2	38.53	24.38	0.98	1.72	3.03	0.82	0.41	1.72
trachea, fetal, donor1	10058-101H4	68.48	14.23	0.38	0.00	3.46	2.31	1.54	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	42.51	12.05	0.00	0.00	2.13	3.54	1.06	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	34.45	30.90	0.00	0.00	0.61	1.11	1.32	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.12	14.42	0.00	0.00	0.47	0.47	1.57	0.16
tridermal teratoma cell line:HGRT	10694-109G1	91.32	13.32	0.00	0.00	3.81	0.00	3.81	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.98	14.05	0.00	0.00	0.25	0.85	0.17	0.08
umbilical cord, fetal, donor1	10057-101H3	77.20	8.35	0.00	0.00	2.09	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	56.65	42.49	1.02	1.37	8.19	1.54	0.51	5.80
uterus, fetal, donor1	10055-101H1	63.99	16.89	0.00	1.02	3.07	2.56	0.51	0.00
vagina, adult	10204-103F6	20.03	21.32	0.00	0.00	1.94	0.00	0.00	0.65
vein, adult	10191-103E2	37.04	18.85	2.19	1.97	3.07	1.32	0.00	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.76	12.02	0.80	0.53	1.07	1.07	0.00	0.00